{
  "test_run_id": "test_run_2025-12-19_10-29-34",
  "timestamp": "2025-12-19T10:29:34.136815",
  "configuration": {
    "api_base_url": "https://gemini-chatbot-480267397633.us-central1.run.app",
    "num_tests": 50,
    "parallel": 5,
    "timeout": 120,
    "save_reports": true,
    "report_dir": "automated_testing/reports"
  },
  "summary": {
    "total_tests": 5,
    "passed": 0,
    "failed": 5,
    "pass_rate": 0.0,
    "average_overall_score": 61.2,
    "average_response_time": 20.641085513188983
  },
  "metrics": {
    "crash_prevention": {
      "average_score": 100.0,
      "passed": 5,
      "failed": 0
    },
    "eligibility_accuracy": {
      "average_score": 0.0,
      "passed": 0,
      "failed": 5
    },
    "conversation_quality": {
      "average_score": 56.0,
      "passed": 3,
      "failed": 2
    },
    "edge_case_handling": {
      "average_score": 100.0,
      "applicable_tests": 1,
      "passed": 5
    },
    "performance": {
      "average_response_time": 20.641085513188983,
      "passed": 3
    }
  },
  "failure_summary": {
    "total_failures": 48,
    "by_type": {
      "eligibility_logic_error": 5,
      "conversation_quality_issue": 41,
      "performance_issue": 2
    }
  },
  "failures": [
    {
      "test_id": "AUTO_TEST_targeted_gout_001",
      "patient_profile": {
        "age": 39,
        "conditions": [
          "Gout",
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find a number in your response. Could y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 20,
        "conditions": [
          "Acne Vulgaris"
        ],
        "medications": [
          "Benzoyl Peroxide",
          "Tretinoin",
          "Doxycycline"
        ]
      },
      "type": "performance_issue",
      "avg_response_time": 24.53239093720913,
      "max_response_time": 56.8698570728302,
      "severity": "low",
      "recommendation": "Investigate slow API responses or Gemini API delays"
    },
    {
      "test_id": "AUTO_TEST_random_001",
      "patient_profile": {
        "age": 62,
        "conditions": [
          "Bipolar Depression",
          "Substance Use"
        ],
        "medications": [
          "Quetiapine",
          "Lithium",
          "Valproate"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_edge_multimorbid_000",
      "patient_profile": {
        "age": 70,
        "conditions": [
          "Bipolar Depression",
          "Major Depressive Disorder",
          "Type 2 Diabetes",
          "Androgenetic Alopecia"
        ],
        "medications": [
          "Biotin",
          "Jardiance",
          "Finasteride",
          "Metformin",
          "Sertraline",
          "Escitalopram",
          "Ozempic"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_edge_multimorbid_000",
      "patient_profile": {
        "age": 70,
        "conditions": [
          "Bipolar Depression",
          "Major Depressive Disorder",
          "Type 2 Diabetes",
          "Androgenetic Alopecia"
        ],
        "medications": [
          "Biotin",
          "Jardiance",
          "Finasteride",
          "Metformin",
          "Sertraline",
          "Escitalopram",
          "Ozempic"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Too few questions asked (4, expected at least 5)",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Too few questions asked (0, expected at least 5)",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "age": 40,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "performance_issue",
      "avg_response_time": 25.387227676808834,
      "max_response_time": 54.476332902908325,
      "severity": "low",
      "recommendation": "Investigate slow API responses or Gemini API delays"
    }
  ],
  "detailed_results": [
    {
      "patient_id": "AUTO_TEST_targeted_gout_001",
      "patient_profile": {
        "patient_id": "AUTO_TEST_targeted_gout_001",
        "profile_type": "targeted",
        "demographics": {
          "age": 39,
          "gender": "female",
          "location": "Charlotte, NC",
          "name": "Test Gout Patient",
          "first_name": "Test",
          "last_name": "Patient"
        },
        "medical_history": {
          "primary_condition": "Gout",
          "conditions": [
            "Gout",
            "Hypertension"
          ],
          "medications": [
            "Lisinopril"
          ],
          "duration_years": 3,
          "flares_per_year": 4,
          "uric_acid_level": 8.5
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            5,
            8
          ],
          "target_trial_keywords": [
            "gout"
          ]
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_targeted_gout_001",
        "patient_id": "AUTO_TEST_targeted_gout_001",
        "conversation_log": [
          {
            "user_message": "Gout trials in Charlotte, NC",
            "bot_response": "Great! I found 1 clinical trial(s) available in Charlotte, NC:\n\n**Dr. Melissa\tJones**\n  \u2022 Gout (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Gout",
                "location": "Charlotte",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Gout",
                  "location": "Charlotte, NC"
                },
                "response_text": "Of course. I can look for clinical trials for Gout in the Charlotte, NC area. Finding the right trial can be a great step. Let me see what I can find for you. Once I pull up the results, I can also help you check if you might be a good fit for any of them.",
                "new_state": "awaiting_user_trial_selection",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both a specific condition ('Gout') and a location ('Charlotte, NC'), which are the necessary pieces of information to perform a trial search. The chosen action `search_trials` directly addresses the user's request. The response confirms the user's query, sets expectations for the search, and proactively offers the next logical step (eligibility prescreening), which is a key principle of the agent."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Gout",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 74,
                  "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                  "conditions": "Gout",
                  "description": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "investigator_name": "Dr. Melissa\tJones",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "total_sites": 13,
                  "similarity_score": 0.7947402273735418
                }
              ],
              "semantic_search": true
            },
            "response_time": 18.3923978805542,
            "timestamp": "2025-12-19T09:59:44.407001"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the gout trial.\n\n**Question 1 of 5:** What is your age?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Great, I can help with that. To see if you might be a match for these Gout trials, I'll need to ask a few questions. This is just a preliminary check and not medical advice.\n\nFirst, could you please tell me your age?",
                "new_state": "prescreening_started",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly agreed to an eligibility check after being shown a list of trials. The current state is 'trials_shown', and we have the necessary condition and location. Therefore, the most appropriate action is to begin the prescreening process by asking the first eligibility question, which is typically age. The state will be updated to 'prescreening_started' to reflect this new phase of the conversation."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 74,
              "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
              "current_question_index": 0,
              "total_questions": 5,
              "current_question": "What is your age?",
              "expected_answer_type": "number"
            },
            "response_time": 17.442317008972168,
            "timestamp": "2025-12-19T10:00:01.849459"
          },
          {
            "user_message": "39",
            "bot_response": "Got it.\n\nHow many flares have you had in the past 12 months?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 39,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for sharing that. Next question: Have you been diagnosed with Gout by a healthcare professional?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just answered the question about their age. The correct action is to continue the prescreening process by asking the next relevant eligibility question. A question about formal diagnosis is a logical and standard next step for a Gout trial, moving the user closer to determining their eligibility."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 5,
              "current_question": "How many flares have you had in the past 12 months?",
              "expected_answer_type": "number",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 19.158780813217163,
            "timestamp": "2025-12-19T10:00:21.008372"
          },
          {
            "user_message": "4",
            "bot_response": "Got it.\n\nAre you currently on stable medication therapy for your condition?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 4,
                "medication": null,
                "number": 4,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it, thanks for sharing that. Just a couple more questions. Are you currently taking any medications specifically for your gout, such as allopurinol or febuxostat?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided a numerical answer ('4') to the previous question. The logical next step is to acknowledge their input and ask the next question in the prescreening sequence to continue assessing their eligibility. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 2,
              "total_questions": 5,
              "current_question": "Are you currently on stable medication therapy for your condition?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 19.149518966674805,
            "timestamp": "2025-12-19T10:00:40.158108"
          },
          {
            "user_message": "Yes, I have Gout",
            "bot_response": "Thank you.\n\nDo you have any known allergies to medications used in this study?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Gout",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for confirming. We're making good progress. Just a couple more questions to go. In the past 6 months, have you experienced a gout flare?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has answered the previous question affirmatively. The most appropriate action is to continue the prescreening process by asking the next logical eligibility question. The response acknowledges their answer, provides encouragement, and asks a relevant follow-up question about recent gout flares to further assess their eligibility for the trial. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 3,
              "total_questions": 5,
              "current_question": "Do you have any known allergies to medications used in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 30.82174777984619,
            "timestamp": "2025-12-19T10:01:10.980024"
          },
          {
            "user_message": "Yes - Lisinopril",
            "bot_response": "Thank you.\n\nHow many attacks have you had in the past 6 months?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": "Lisinopril",
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for letting me know. Just a couple more questions to check if this trial might be a good fit. Do you have any other major health conditions, such as kidney disease, heart problems, or diabetes?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "condition"
                ],
                "metadata": {
                  "reasoning": "The user is in the 'prescreening_active' state and has answered the previous question by providing a medication they are taking. The logical next step is to continue the prescreening process by acknowledging their input and asking the next relevant eligibility question to further assess if the trial is a potential match."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 4,
              "total_questions": 5,
              "current_question": "How many attacks have you had in the past 6 months?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 26.0137619972229,
            "timestamp": "2025-12-19T10:01:36.994062"
          },
          {
            "user_message": "4",
            "bot_response": "I couldn't determine if your answer is yes or no. Could you please respond with 'yes' or 'no'?\n\nPlease answer: 'yes' or 'no'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 4,
                "medication": null,
                "number": 4,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it, thank you. The next question is about medication. Are you currently taking any medication to lower your uric acid, such as allopurinol or febuxostat?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided a numerical answer to the previous question. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The next question about medication is a standard criterion for Gout trials and moves the user closer to determining their potential eligibility."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 4
            },
            "response_time": 20.590049982070923,
            "timestamp": "2025-12-19T10:01:57.585448"
          },
          {
            "user_message": "Yes",
            "bot_response": "Thanks for completing the prescreening! I have a few questions that need clarification:\n\n\u2713 Age: 39\n\u2713 4 flares in specified period\n\u2713 Current medications: Yes\n\u2713 Allergies: Yes\n? Episodes/Count: Yes - needs clarification\n\nWould you like to:\n1. Continue with your current answers\n2. Update any responses\n\nPlease respond with '1' to continue or '2' to make changes.",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thanks for confirming. Next question: Are you currently taking a medication called allopurinol, which is sometimes sold under the brand names Zyloprim or Aloprim?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided a direct 'Yes' to the previous question. The correct action is to continue the prescreening process by asking the next eligibility question. This moves the user forward in their goal of checking their potential eligibility for the trial."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "pending_evaluation": true,
              "eligibility_result": {
                "trial_id": 74,
                "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                "overall_status": "likely_ineligible",
                "inclusion_met": 2,
                "inclusion_total": 3,
                "exclusion_met": 0,
                "exclusion_total": 2,
                "detailed_results": [
                  {
                    "criterion_id": 1706,
                    "criterion_text": "Age \u226518 years",
                    "user_answer": "39",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "39.0 meets minimum requirement of \u226518.0"
                  },
                  {
                    "criterion_id": 1708,
                    "criterion_text": "At least 2 gout flares in the 12 months prior to Screening",
                    "user_answer": "4",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "4.0 meets minimum requirement of \u22652.0"
                  },
                  {
                    "criterion_id": 1709,
                    "criterion_text": "On a stable background allopurinol dose of \u2265300 mg (200 mg for those with moderate renal impairment [eGFR 30 to <60 mL/min/1.73 m\u00b2]) up to 600 mg QD for at least 3 months prior to Screening",
                    "user_answer": "Yes, I have Gout",
                    "eligible": null,
                    "status": "needs_review",
                    "explanation": "Answer 'Yes, I have Gout' for criterion 'On a stable background allopurinol dose of \u2265300 mg (200 mg for those with moderate renal impairment [eGFR 30 to <60 mL/min/1.73 m\u00b2]) up to 600 mg QD for at least 3 months prior to Screening' requires manual review by study staff"
                  },
                  {
                    "criterion_id": 1714,
                    "criterion_text": "Participants with a known hypersensitivity to dotinurad or allopurinol or any component of their formulations.",
                    "user_answer": "Yes - Lisinopril",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  },
                  {
                    "criterion_id": 1719,
                    "criterion_text": "Participants with a history of clinically significant cardiovascular disease, including unstable angina, myocardial infarction, stroke, or transient ischemic attack within the past 6 months.",
                    "user_answer": "Yes",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  }
                ],
                "summary_text": "Eligibility Summary for the gout trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/2\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2717 Has relevant medical condition\n\u2713 Age 39 (meets requirement)\n\u2713 4 gout flares (meets requirement)\n"
              },
              "summary": "\u2713 Age: 39\n\u2713 4 flares in specified period\n\u2713 Current medications: Yes\n\u2713 Allergies: Yes\n? Episodes/Count: Yes - needs clarification"
            },
            "response_time": 23.87808394432068,
            "timestamp": "2025-12-19T10:02:21.463693"
          },
          {
            "user_message": "Yes, everything is correct. Please continue with the eligibility evaluation.",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thanks for confirming. Next question: Are you currently taking a medication called allopurinol, which is sometimes sold under the brand names Zyloprim or Aloprim?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided a direct 'Yes' to the previous question. The correct action is to continue the prescreening process by asking the next eligibility question. This moves the user forward in their goal of checking their potential eligibility for the trial."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Gout",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 74,
                  "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                  "conditions": "Gout",
                  "description": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "investigator_name": "Dr. Melissa\tJones",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "total_sites": 13,
                  "similarity_score": 0.7947402273735418
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 74,
              "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
              "current_question_index": 4,
              "total_questions": 5,
              "current_question": "How many attacks have you had in the past 6 months?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "pending_evaluation": true,
              "eligibility_result": {
                "trial_id": 74,
                "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                "overall_status": "likely_ineligible",
                "inclusion_met": 2,
                "inclusion_total": 3,
                "exclusion_met": 0,
                "exclusion_total": 2,
                "detailed_results": [
                  {
                    "criterion_id": 1706,
                    "criterion_text": "Age \u226518 years",
                    "user_answer": "39",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "39.0 meets minimum requirement of \u226518.0"
                  },
                  {
                    "criterion_id": 1708,
                    "criterion_text": "At least 2 gout flares in the 12 months prior to Screening",
                    "user_answer": "4",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "4.0 meets minimum requirement of \u22652.0"
                  },
                  {
                    "criterion_id": 1709,
                    "criterion_text": "On a stable background allopurinol dose of \u2265300 mg (200 mg for those with moderate renal impairment [eGFR 30 to <60 mL/min/1.73 m\u00b2]) up to 600 mg QD for at least 3 months prior to Screening",
                    "user_answer": "Yes, I have Gout",
                    "eligible": null,
                    "status": "needs_review",
                    "explanation": "Answer 'Yes, I have Gout' for criterion 'On a stable background allopurinol dose of \u2265300 mg (200 mg for those with moderate renal impairment [eGFR 30 to <60 mL/min/1.73 m\u00b2]) up to 600 mg QD for at least 3 months prior to Screening' requires manual review by study staff"
                  },
                  {
                    "criterion_id": 1714,
                    "criterion_text": "Participants with a known hypersensitivity to dotinurad or allopurinol or any component of their formulations.",
                    "user_answer": "Yes - Lisinopril",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  },
                  {
                    "criterion_id": 1719,
                    "criterion_text": "Participants with a history of clinically significant cardiovascular disease, including unstable angina, myocardial infarction, stroke, or transient ischemic attack within the past 6 months.",
                    "user_answer": "Yes",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  }
                ],
                "summary_text": "Eligibility Summary for the gout trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/2\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2717 Has relevant medical condition\n\u2713 Age 39 (meets requirement)\n\u2713 4 gout flares (meets requirement)\n"
              },
              "summary": "\u2713 Age: 39\n\u2713 4 flares in specified period\n\u2713 Current medications: Yes\n\u2713 Allergies: Yes\n? Episodes/Count: Yes - needs clarification"
            },
            "response_time": 11.924767971038818,
            "timestamp": "2025-12-19T10:02:33.389750"
          },
          {
            "user_message": "Yes, please continue",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thanks for confirming. Next question: Are you currently taking a medication called allopurinol, which is sometimes sold under the brand names Zyloprim or Aloprim?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided a direct 'Yes' to the previous question. The correct action is to continue the prescreening process by asking the next eligibility question. This moves the user forward in their goal of checking their potential eligibility for the trial."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Gout",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 74,
                  "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                  "conditions": "Gout",
                  "description": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "investigator_name": "Dr. Melissa\tJones",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "total_sites": 13,
                  "similarity_score": 0.7947402273735418
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 74,
              "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
              "current_question_index": 4,
              "total_questions": 5,
              "current_question": "How many attacks have you had in the past 6 months?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "pending_evaluation": true,
              "eligibility_result": {
                "trial_id": 74,
                "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                "overall_status": "likely_ineligible",
                "inclusion_met": 2,
                "inclusion_total": 3,
                "exclusion_met": 0,
                "exclusion_total": 2,
                "detailed_results": [
                  {
                    "criterion_id": 1706,
                    "criterion_text": "Age \u226518 years",
                    "user_answer": "39",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "39.0 meets minimum requirement of \u226518.0"
                  },
                  {
                    "criterion_id": 1708,
                    "criterion_text": "At least 2 gout flares in the 12 months prior to Screening",
                    "user_answer": "4",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "4.0 meets minimum requirement of \u22652.0"
                  },
                  {
                    "criterion_id": 1709,
                    "criterion_text": "On a stable background allopurinol dose of \u2265300 mg (200 mg for those with moderate renal impairment [eGFR 30 to <60 mL/min/1.73 m\u00b2]) up to 600 mg QD for at least 3 months prior to Screening",
                    "user_answer": "Yes, I have Gout",
                    "eligible": null,
                    "status": "needs_review",
                    "explanation": "Answer 'Yes, I have Gout' for criterion 'On a stable background allopurinol dose of \u2265300 mg (200 mg for those with moderate renal impairment [eGFR 30 to <60 mL/min/1.73 m\u00b2]) up to 600 mg QD for at least 3 months prior to Screening' requires manual review by study staff"
                  },
                  {
                    "criterion_id": 1714,
                    "criterion_text": "Participants with a known hypersensitivity to dotinurad or allopurinol or any component of their formulations.",
                    "user_answer": "Yes - Lisinopril",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  },
                  {
                    "criterion_id": 1719,
                    "criterion_text": "Participants with a history of clinically significant cardiovascular disease, including unstable angina, myocardial infarction, stroke, or transient ischemic attack within the past 6 months.",
                    "user_answer": "Yes",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  }
                ],
                "summary_text": "Eligibility Summary for the gout trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/2\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2717 Has relevant medical condition\n\u2713 Age 39 (meets requirement)\n\u2713 4 gout flares (meets requirement)\n"
              },
              "summary": "\u2713 Age: 39\n\u2713 4 flares in specified period\n\u2713 Current medications: Yes\n\u2713 Allergies: Yes\n? Episodes/Count: Yes - needs clarification"
            },
            "response_time": 9.228417158126831,
            "timestamp": "2025-12-19T10:02:42.621340"
          },
          {
            "user_message": "Yes, please continue",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_001",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thanks for confirming. Next question: Are you currently taking a medication called allopurinol, which is sometimes sold under the brand names Zyloprim or Aloprim?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided a direct 'Yes' to the previous question. The correct action is to continue the prescreening process by asking the next eligibility question. This moves the user forward in their goal of checking their potential eligibility for the trial."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Gout",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 74,
                  "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                  "conditions": "Gout",
                  "description": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "investigator_name": "Dr. Melissa\tJones",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "total_sites": 13,
                  "similarity_score": 0.7947402273735418
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 74,
              "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
              "current_question_index": 4,
              "total_questions": 5,
              "current_question": "How many attacks have you had in the past 6 months?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "pending_evaluation": true,
              "eligibility_result": {
                "trial_id": 74,
                "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                "overall_status": "likely_ineligible",
                "inclusion_met": 2,
                "inclusion_total": 3,
                "exclusion_met": 0,
                "exclusion_total": 2,
                "detailed_results": [
                  {
                    "criterion_id": 1706,
                    "criterion_text": "Age \u226518 years",
                    "user_answer": "39",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "39.0 meets minimum requirement of \u226518.0"
                  },
                  {
                    "criterion_id": 1708,
                    "criterion_text": "At least 2 gout flares in the 12 months prior to Screening",
                    "user_answer": "4",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "4.0 meets minimum requirement of \u22652.0"
                  },
                  {
                    "criterion_id": 1709,
                    "criterion_text": "On a stable background allopurinol dose of \u2265300 mg (200 mg for those with moderate renal impairment [eGFR 30 to <60 mL/min/1.73 m\u00b2]) up to 600 mg QD for at least 3 months prior to Screening",
                    "user_answer": "Yes, I have Gout",
                    "eligible": null,
                    "status": "needs_review",
                    "explanation": "Answer 'Yes, I have Gout' for criterion 'On a stable background allopurinol dose of \u2265300 mg (200 mg for those with moderate renal impairment [eGFR 30 to <60 mL/min/1.73 m\u00b2]) up to 600 mg QD for at least 3 months prior to Screening' requires manual review by study staff"
                  },
                  {
                    "criterion_id": 1714,
                    "criterion_text": "Participants with a known hypersensitivity to dotinurad or allopurinol or any component of their formulations.",
                    "user_answer": "Yes - Lisinopril",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  },
                  {
                    "criterion_id": 1719,
                    "criterion_text": "Participants with a history of clinically significant cardiovascular disease, including unstable angina, myocardial infarction, stroke, or transient ischemic attack within the past 6 months.",
                    "user_answer": "Yes",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  }
                ],
                "summary_text": "Eligibility Summary for the gout trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/2\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2717 Has relevant medical condition\n\u2713 Age 39 (meets requirement)\n\u2713 4 gout flares (meets requirement)\n"
              },
              "summary": "\u2713 Age: 39\n\u2713 4 flares in specified period\n\u2713 Current medications: Yes\n\u2713 Allergies: Yes\n? Episodes/Count: Yes - needs clarification"
            },
            "response_time": 3.243767023086548,
            "timestamp": "2025-12-19T10:02:45.865279"
          }
        ],
        "final_state": "completed",
        "total_turns": 11,
        "total_questions_asked": 5,
        "errors": [
          {
            "type": "unexpected_state",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your respo"
          },
          {
            "type": "unexpected_state",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your respo"
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 70.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": true,
          "score": 100.0,
          "total_questions_asked": 5,
          "issues": [],
          "failures": []
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": false,
          "failures": []
        },
        "performance": {
          "passed": true,
          "score": 70.0,
          "avg_response_time": 18.16760095683011,
          "max_response_time": 30.82174777984619,
          "status": "acceptable",
          "failures": []
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py"
        ]
      },
      "timestamp": "2025-12-19T10:02:45.865525"
    },
    {
      "patient_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "patient_id": "AUTO_TEST_random_000",
        "profile_type": "random",
        "demographics": {
          "age": 20,
          "gender": "non-binary",
          "location": "New Orleans, LA",
          "name": "Linda Johnson",
          "first_name": "Linda",
          "last_name": "Johnson"
        },
        "medical_history": {
          "primary_condition": "Acne Vulgaris",
          "conditions": [
            "Acne Vulgaris"
          ],
          "medications": [
            "Benzoyl Peroxide",
            "Tretinoin",
            "Doxycycline"
          ],
          "duration_years": 7
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            4,
            8
          ]
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_random_000",
        "patient_id": "AUTO_TEST_random_000",
        "conversation_log": [
          {
            "user_message": "Acne Vulgaris trials in New Orleans, LA",
            "bot_response": "Great! I found 2 clinical trial(s) available in New Orleans, LA:\n\n**Dr. Deidre Hooper**\n  \u2022 Acne Vulgaris (2 trials)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Acne Vulgaris",
                "location": "New Orleans",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Acne Vulgaris",
                  "location": "New Orleans, LA"
                },
                "response_text": "Of course, I can look for clinical trials for Acne Vulgaris in the New Orleans area. Let me search for you now. Once I have the results, I can also help you go through a few questions to see if you might be eligible for any of them, if you'd like.",
                "new_state": "awaiting_search_results",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both a specific condition ('Acne Vulgaris') and a location ('New Orleans, LA'). Therefore, the `search_trials` action is the most appropriate next step to directly fulfill their request. The response confirms the search parameters, sets expectations, and proactively offers the next logical step (eligibility prescreening) to guide the conversation forward."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 2,
              "condition": "Acne Vulgaris",
              "location": "New Orleans, LA",
              "trials_data": [
                {
                  "id": 84,
                  "trial_name": "A Phase 1/2, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy and immunogenicity of an Acne mRNA vaccine candidate in participants with mild acne",
                  "conditions": "Acne Vulgaris",
                  "description": "This is a Phase 1/2, multi-center, randomized, double-blind, placebo-controlled study sponsored by Sanofi.  The study will be conducted in Singapore and potentially other countries.  This means that some participants will receive the acne vaccine and others will receive a placebo, and neither the participants nor the researchers will know who received which until the end of the study.  The study aims to evaluate the safety and effectiveness of two doses of an mRNA vaccine for mild acne. The duration of the study is not explicitly stated in the provided excerpt but includes a sentinel cohort followed by a main cohort and a long-term follow-up.\n\nThis study is looking for participants aged 18 to 45 years old with mild facial acne vulgaris.  To qualify, you must have an IGA score of mild (grade 2), 10-24 non-inflammatory lesions (like blackheads and whiteheads), and 5-19 inflammatory lesions (like papules and pustules), but no nodulocystic lesions.  Women must not be pregnant or breastfeeding and must use effective contraception or be post-menopausal/surgically sterile.  You cannot participate if you have certain medical conditions like immunodeficiency, allergies to vaccine components, history of myocarditis/pericarditis, chronic illness, bleeding disorders, or severe forms of acne.  Several acne treatments require a washout period before joining the study, ranging from 2 to 24 weeks depending on the treatment.  You should be able to attend all scheduled visits and comply with study procedures.\n\nParticipants will receive two administrations of either the acne mRNA vaccine or a placebo.  The study will measure the safety, effectiveness, and how the vaccine affects the immune system.  Safety will be assessed by monitoring for any side effects.  Effectiveness will be evaluated by measuring changes in acne lesions.  Immunogenicity will be assessed by measuring the body's immune response to the vaccine.  The visit schedule and specific procedures are not fully detailed in this summary, but will involve regular check-ups to assess your acne and monitor for any side effects.  The protocol mentions a sentinel cohort which will have a modified double-blind approach where site staff administering the vaccine and some sponsor staff will be unblinded.",
                  "investigator_name": "Dr. Deidre Hooper",
                  "site_location": "New Orleans, LA",
                  "protocol_summary": "This is a Phase 1/2, multi-center, randomized, double-blind, placebo-controlled study sponsored by Sanofi.  The study will be conducted in Singapore and potentially other countries.  This means that some participants will receive the acne vaccine and others will receive a placebo, and neither the participants nor the researchers will know who received which until the end of the study.  The study aims to evaluate the safety and effectiveness of two doses of an mRNA vaccine for mild acne. The duration of the study is not explicitly stated in the provided excerpt but includes a sentinel cohort followed by a main cohort and a long-term follow-up.\n\nThis study is looking for participants aged 18 to 45 years old with mild facial acne vulgaris.  To qualify, you must have an IGA score of mild (grade 2), 10-24 non-inflammatory lesions (like blackheads and whiteheads), and 5-19 inflammatory lesions (like papules and pustules), but no nodulocystic lesions.  Women must not be pregnant or breastfeeding and must use effective contraception or be post-menopausal/surgically sterile.  You cannot participate if you have certain medical conditions like immunodeficiency, allergies to vaccine components, history of myocarditis/pericarditis, chronic illness, bleeding disorders, or severe forms of acne.  Several acne treatments require a washout period before joining the study, ranging from 2 to 24 weeks depending on the treatment.  You should be able to attend all scheduled visits and comply with study procedures.\n\nParticipants will receive two administrations of either the acne mRNA vaccine or a placebo.  The study will measure the safety, effectiveness, and how the vaccine affects the immune system.  Safety will be assessed by monitoring for any side effects.  Effectiveness will be evaluated by measuring changes in acne lesions.  Immunogenicity will be assessed by measuring the body's immune response to the vaccine.  The visit schedule and specific procedures are not fully detailed in this summary, but will involve regular check-ups to assess your acne and monitor for any side effects.  The protocol mentions a sentinel cohort which will have a modified double-blind approach where site staff administering the vaccine and some sponsor staff will be unblinded.",
                  "total_sites": 1,
                  "similarity_score": 0.8269423983009184
                },
                {
                  "id": 90,
                  "trial_name": "A Phase I/II, randomized, placebo-controlled, multi-arm, dose-finding study to evaluate the safety, efficacy and immunogenicity of an Acne mRNA vaccine candidate in adults with moderate to severe acne 18 to 45 years of age",
                  "conditions": "Acne Vulgaris",
                  "description": "This is a Phase I/II study, meaning it's one of the first times this acne vaccine is being tested in humans.  The study is randomized, which means participants are assigned to different treatment groups by chance, like flipping a coin. Some participants will receive the vaccine, while others will receive a placebo (an inactive substance).  This helps researchers understand if the vaccine is truly effective.  The study is also 'double-blinded' (or 'modified double-blind' in some parts), meaning neither the participants nor the researchers know who is getting the vaccine or the placebo until the end of the study. Sanofi is sponsoring the study, which will be conducted at multiple sites in the US and potentially other countries. The study duration will depend on the dose and cohort, but will involve multiple visits over several months.\n\nThis study is looking for adults between 18 and 45 years old who have moderate to severe acne.  To qualify, you must have a certain number of pimples, blackheads, and whiteheads, as determined by a doctor.  You must be generally healthy and able to attend all scheduled study visits.  You cannot participate if you have certain medical conditions, like a weakened immune system, a history of heart inflammation (myocarditis or pericarditis), or certain skin conditions.  You also can't participate if you've recently received other vaccines, taken certain acne medications (like isotretinoin), or are pregnant or breastfeeding.  If you are eligible and choose to participate, you'll need to avoid other acne treatments during the study and follow the instructions provided by the study team.\n\nIn this study, participants will receive either the acne mRNA vaccine or a placebo by injection.  Researchers will be looking at how safe the vaccine is, how well it works to reduce acne, and how the body's immune system responds to it.  The main measurements will be the change in the number of acne lesions, how your skin looks overall, and the presence of antibodies against acne-causing bacteria in your blood.  You'll need to visit the study site several times over the course of the study for check-ups, assessments, and to receive the study injections. The exact schedule will depend on which part of the study you are in, but will likely involve visits over several months.  During these visits, doctors will examine your skin, take blood samples, and ask you about any side effects you may be experiencing.",
                  "investigator_name": "Dr. Deidre Hooper",
                  "site_location": "New Orleans, LA",
                  "protocol_summary": "This is a Phase I/II study, meaning it's one of the first times this acne vaccine is being tested in humans.  The study is randomized, which means participants are assigned to different treatment groups by chance, like flipping a coin. Some participants will receive the vaccine, while others will receive a placebo (an inactive substance).  This helps researchers understand if the vaccine is truly effective.  The study is also 'double-blinded' (or 'modified double-blind' in some parts), meaning neither the participants nor the researchers know who is getting the vaccine or the placebo until the end of the study. Sanofi is sponsoring the study, which will be conducted at multiple sites in the US and potentially other countries. The study duration will depend on the dose and cohort, but will involve multiple visits over several months.\n\nThis study is looking for adults between 18 and 45 years old who have moderate to severe acne.  To qualify, you must have a certain number of pimples, blackheads, and whiteheads, as determined by a doctor.  You must be generally healthy and able to attend all scheduled study visits.  You cannot participate if you have certain medical conditions, like a weakened immune system, a history of heart inflammation (myocarditis or pericarditis), or certain skin conditions.  You also can't participate if you've recently received other vaccines, taken certain acne medications (like isotretinoin), or are pregnant or breastfeeding.  If you are eligible and choose to participate, you'll need to avoid other acne treatments during the study and follow the instructions provided by the study team.\n\nIn this study, participants will receive either the acne mRNA vaccine or a placebo by injection.  Researchers will be looking at how safe the vaccine is, how well it works to reduce acne, and how the body's immune system responds to it.  The main measurements will be the change in the number of acne lesions, how your skin looks overall, and the presence of antibodies against acne-causing bacteria in your blood.  You'll need to visit the study site several times over the course of the study for check-ups, assessments, and to receive the study injections. The exact schedule will depend on which part of the study you are in, but will likely involve visits over several months.  During these visits, doctors will examine your skin, take blood samples, and ask you about any side effects you may be experiencing.",
                  "total_sites": 5,
                  "similarity_score": 0.824062748725711
                }
              ],
              "semantic_search": true
            },
            "response_time": 17.006946086883545,
            "timestamp": "2025-12-19T09:59:43.022777"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the acne vulgaris trial.\n\n**Question 1 of 4:** How old were you when this condition first started?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Of course. I can help with that. I'll ask a few simple questions based on the general eligibility criteria for the Acne Vulgaris trials we found. This will help us see if you might be a good match. \n\nFirst, could you please tell me your age?",
                "new_state": "prescreening_in_progress",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly requested to check their eligibility after being shown a list of trials. The current state is 'trials_shown', making this the perfect transition point. The 'start_prescreening' action initiates the eligibility questionnaire, starting with a common and non-sensitive question like age, to help determine if the user is a potential match for the trials."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 84,
              "trial_name": "A Phase 1/2, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy and immunogenicity of an Acne mRNA vaccine candidate in participants with mild acne",
              "current_question_index": 0,
              "total_questions": 4,
              "current_question": "How old were you when this condition first started?",
              "expected_answer_type": "number"
            },
            "response_time": 18.47584104537964,
            "timestamp": "2025-12-19T10:00:01.498782"
          },
          {
            "user_message": "20",
            "bot_response": "Got it.\n\nDo you have any of the following: Known or suspected congenital or acquired immunodeficiency; or receipt of immunosuppressive therapy, such as anti-cancer chemotherapy or radiation therapy, within 6 months prior to the first study intervention administration; or long-term systemic corticosteroid therapy (prednisone or equivalent for more than 2 consecutive weeks within the past 3 months)?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 20,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for sharing. Next question: On average, how many inflammatory lesions (papules or pustules) do you have on your face?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided an answer to the previous question. The logical next step is to continue with the prescreening flow by asking the next relevant question to determine their eligibility for the trial. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 4,
              "current_question": "Do you have any of the following: Known or suspected congenital or acquired immunodeficiency; or receipt of immunosuppressive therapy, such as anti-cancer chemotherapy or radiation therapy, within 6 months prior to the first study intervention administration; or long-term systemic corticosteroid therapy (prednisone or equivalent for more than 2 consecutive weeks within the past 3 months)?",
              "expected_answer_type": "number",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 19.67904281616211,
            "timestamp": "2025-12-19T10:00:21.178077"
          },
          {
            "user_message": "I'm not sure, can you clarify?",
            "bot_response": "I'm here to help you find clinical trials. What condition are you interested in?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "I'm here to help you find clinical trials. What condition are you interested in?",
                "new_state": "initial",
                "collect_entities": null,
                "metadata": {
                  "fallback": true
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 56.8698570728302,
            "timestamp": "2025-12-19T10:01:18.048085"
          },
          {
            "user_message": "Yes, I have Acne Vulgaris",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Acne Vulgaris",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thank you for confirming that. The next question is about age. Could you please tell me how old you are?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has answered a prescreening question, confirming their condition. The current state is 'prescreening_active', indicating we are in the middle of an eligibility check. The most appropriate next step is to continue with the prescreening process by asking the next question in the sequence. Asking for their age is a common and logical next step for most clinical trials, which keeps the user engaged and moves them closer to determining their potential eligibility."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.411724090576172,
            "timestamp": "2025-12-19T10:01:41.460101"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it. Thanks for confirming. The next question is: Are you currently taking any prescription medications for your acne, either oral or topical?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (`prescreening_active` state) and has provided a direct 'Yes' answer to the previous question. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. This moves the user closer to their goal of determining potential eligibility for the trial while maintaining the conversational flow."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.97281503677368,
            "timestamp": "2025-12-19T10:02:04.433784"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To be more specific, could you please provide a number? For example, approximately how many pimples or acne spots do you currently have on your face?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has responded with a boolean 'Yes' when a numerical answer was expected. The most appropriate action is to continue the prescreening by gently clarifying the type of information needed (a number) and re-prompting with a clear example. This keeps the conversation on track and helps the user provide the necessary information to continue the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.106423139572144,
            "timestamp": "2025-12-19T10:02:26.540354"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "reprompt": true
                },
                "response_text": "Thanks for confirming. My apologies if my last question wasn't clear. To continue checking your eligibility, could you please provide that information as a number?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a 'Yes' answer. The conversation context indicates a numerical answer was expected. The user's response is a data type mismatch. The best action is to continue the prescreening by gently re-prompting for the correct information (a number) to get the conversation back on track without causing confusion."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.522693872451782,
            "timestamp": "2025-12-19T10:02:50.063187"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies, I should have been clearer! For this particular question, I need a number. Could you please tell me your age in years?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow and provided a boolean answer ('Yes') when a numeric value was expected. The OpenAI reasoning correctly identifies this mismatch. The best action is to continue the prescreening by gently re-prompting for the correct type of information. The response clarifies the need for a number, re-asks the question (assuming the last question was about age, a common numeric prescreener), and maintains a helpful, supportive tone. The state remains 'prescreening_active' as we are still in the middle of the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.846943855285645,
            "timestamp": "2025-12-19T10:03:13.910254"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. My apologies if my last question wasn't clear. To continue checking your eligibility for this Acne Vulgaris study, I'll need a specific piece of information. Could you please tell me your age in years?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user provided a boolean 'Yes' response when the system was in a prescreening state, likely expecting a numerical answer (e.g., age, number of lesions). The current action is to continue the prescreening process by gracefully handling this mismatch. The response clarifies the need for a specific piece of information (assuming it was age, a common first prescreening question) and re-asks the question clearly. This keeps the conversation on track without making the user feel they made an error, and sets the system to collect the 'age' entity from the next response."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 21.891050100326538,
            "timestamp": "2025-12-19T10:03:35.801433"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies, I think my last question wasn't clear. I was looking for a number to help check the study's requirements. Could you please tell me again, but with a specific number? For example, if I asked how many pimples you have, you could say 'about 25'. Let's try that question again.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user provided a boolean 'Yes' when a numeric value was expected, as noted in the OpenAI reasoning. This indicates a conversational breakdown or a loop. The best action is to clarify the required input format to get the conversation back on track. The response apologizes for the confusion (taking responsibility), explains *why* a number is needed (for study requirements), and provides a clear example. This approach is empathetic and aims to break the loop by re-engaging the user with a clearer request, thus continuing the prescreening process."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.62803888320923,
            "timestamp": "2025-12-19T10:04:00.429595"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. My apologies if my last question wasn't clear. To make sure I have the right information, could you please provide an approximate number? I'm trying to understand how many inflamed spots or pimples you currently have.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user responded with 'Yes' when a numerical answer was expected during an active prescreening. The most appropriate action is to continue the prescreening by gently clarifying the previous question and re-prompting for the correct type of information (a number). This approach is helpful, avoids confusion, and keeps the eligibility check moving forward without making the user feel they made an error. The state remains 'prescreening_active' as we are still on the same screening question."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.613099098205566,
            "timestamp": "2025-12-19T10:04:23.042821"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "answer": true
                },
                "response_text": "Got it. Thanks for confirming. Just a couple more questions to go. Have you used any prescription topical or oral acne medications in the past 30 days?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a 'Yes' answer to the previous question. The most appropriate action is to continue the prescreening flow by acknowledging their response and asking the next question in the sequence. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 18.586273908615112,
            "timestamp": "2025-12-19T10:04:41.629677"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies if my last question was unclear. For this step, I actually need a specific number. Could you please provide your best estimate for the number of pimples or inflamed spots you currently have on your face?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening and provided a 'Yes' response when a numeric value was expected. The chosen action is to continue the prescreening by clarifying the required input format and re-asking the question. This approach is helpful, non-judgmental, and effectively moves the conversation forward by gathering the necessary information to assess eligibility. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 18.377480268478394,
            "timestamp": "2025-12-19T10:05:00.007847"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies, I think I got my wires crossed there. I was looking for a number. Could you please tell me again how many inflammatory lesions (pimples) you currently have on your face? An approximate number is perfectly fine.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided a boolean answer ('Yes') where a numeric value was likely expected. The most appropriate action is to continue the prescreening by politely re-asking the previous question and clarifying the required input format. This response takes responsibility for the miscommunication, provides a clear example of the needed information, and keeps the user engaged in the eligibility check without changing the conversation state."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 18.56669807434082,
            "timestamp": "2025-12-19T10:05:18.575043"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To make sure I'm checking the eligibility criteria correctly, I'll need a number for that last question. Could you please provide the number for me?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided a boolean 'Yes' answer to a question that, based on the context, required a numerical input. The chosen action is 'continue_prescreening' because the primary goal is to get the necessary information to proceed with the eligibility check. The response gently clarifies the need for a number without making the user feel they made an error, explains why it's needed ('to check the eligibility criteria correctly'), and re-prompts for the correct information. The state remains 'prescreening_active' as we are still in the middle of this process."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 21.764708042144775,
            "timestamp": "2025-12-19T10:05:40.340235"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it. Thanks for confirming. Just a couple more questions to go. In the past 30 days, have you used any prescription topical or oral medications for your acne?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a direct 'Yes' answer to the previous question. The correct action is to continue the process by asking the next logical question in the eligibility sequence. A question about recent medication use is a standard and crucial part of screening for an acne trial. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 19.64873719215393,
            "timestamp": "2025-12-19T10:05:59.989615"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "user_input": "Yes",
                  "boolean_answer": true
                },
                "response_text": "My apologies, I think my last question may have been a bit confusing. I was looking for a specific number. Could you please try answering that again for me?",
                "new_state": "prescreening_active",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a 'Yes' response, which likely doesn't match the expected input for the previous question (e.g., a number for age or lesion count). The most appropriate action is to continue the prescreening by gently clarifying that a different type of answer is needed and re-prompting. This keeps the conversation on track without making the user feel they made a mistake. The state remains 'prescreening_active' because we are still on the same step of the process."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.46053409576416,
            "timestamp": "2025-12-19T10:06:22.450989"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies if my last question wasn't clear. I was looking for a number to help check your eligibility. Could you please tell me approximately how many active pimples you currently have?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a 'Yes' response, which is an invalid answer to the previous question that required a numerical input. The chosen action is `continue_prescreening` to re-prompt the user for the correct information. The response is empathetic, clarifies the type of information needed (a number), and re-asks the question to get the conversation back on track without making the user feel they made a mistake."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.83234214782715,
            "timestamp": "2025-12-19T10:06:45.285446"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "user_answer": "Yes"
                },
                "response_text": "Okay, thank you for confirming. We're almost done with these initial questions. Have you used any prescription topical or oral acne medications in the last 30 days?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided a direct 'Yes' to the previous eligibility question. The correct action is to continue the prescreening flow. This involves acknowledging their answer, asking the next logical question to further assess eligibility, and maintaining the 'prescreening_active' state as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 20.308358192443848,
            "timestamp": "2025-12-19T10:07:05.594329"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies if my last question wasn't clear. I was looking for a number to answer that. Could you please provide the information as a numeric value?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow but provided a boolean ('Yes') when a numeric value was expected, as indicated by the OpenAI reasoning. The best action is to continue the prescreening by politely clarifying the required input format and re-prompting for a number. This keeps the conversation on track without making the user feel they made an error. The state remains 'prescreening_active' as we are still in the middle of the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.298091173171997,
            "timestamp": "2025-12-19T10:07:27.892886"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it. Thanks for confirming. Next question: Have you had acne for at least 6 months?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a simple affirmative answer. The most appropriate action is to continue with the next question in the prescreening script to maintain momentum and help the user complete the eligibility check. The state remains 'prescreening_active' as the process is ongoing. The next question is a standard yes/no question relevant to an acne trial."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 21.946722984313965,
            "timestamp": "2025-12-19T10:07:49.840209"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "I appreciate you working through these questions with me. It looks like this specific question requires a number. Could you please provide an estimate? For example, you could say 'about 25' or just enter the number. We're getting close to the end!",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow but provided a boolean 'Yes' to a question that, based on the context, requires a numeric value. The chosen action, `continue_prescreening`, keeps the user in the eligibility check flow. The response is designed to be empathetic and gently re-prompts for the correct information type (a number), providing an example to reduce confusion and encouraging the user to continue, which is important given the long conversation history."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.88468074798584,
            "timestamp": "2025-12-19T10:08:14.725436"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies, I was expecting a number for that last question. Could you please provide an estimate of how many pimples you currently have on your face? A rough guess is all that's needed.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow and responded with 'Yes' to a question that, based on the context, likely required a numerical answer. The chosen action is `continue_prescreening` to re-prompt the user for the correct information type (a number) so we can proceed with the eligibility check. The response is designed to be gentle and clear, guiding the user without making them feel they made a mistake."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 19.18183398246765,
            "timestamp": "2025-12-19T10:08:33.907766"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it. Thanks for confirming. Next question: Have you used any prescription topical or oral acne medications in the past 30 days?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided a direct 'Yes' answer to the previous question. The correct action is to continue the prescreening process by asking the next eligibility question. The response acknowledges their answer and poses the next logical question for an acne trial, which is about recent medication use, to move them closer to determining their potential eligibility."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 18.960402011871338,
            "timestamp": "2025-12-19T10:08:52.868918"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "user_answer": "Yes"
                },
                "response_text": "Thanks for confirming. My apologies, I may not have been clear. The last question requires a specific number to help determine eligibility. Could you please provide an estimate for that last question I asked?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow and responded with 'Yes'. The context suggests the previous question required a different input type, likely a number. The best action is to gently clarify the need for a specific format and re-ask the question. This keeps the user engaged in the prescreening process without causing confusion. The state remains 'prescreening_active' as we are still trying to resolve the current eligibility question."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 52.56650114059448,
            "timestamp": "2025-12-19T10:09:45.435877"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it. The next question is: Are you currently taking any oral antibiotics, such as doxycycline or minocycline, for your acne?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided a direct boolean answer ('Yes') to the previous question. The correct action is to continue the prescreening process by acknowledging their response and asking the next question in the sequence. The state remains 'prescreening_active' because the screener is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 20.671459913253784,
            "timestamp": "2025-12-19T10:10:06.108596"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "I appreciate the quick response! It looks like that last question needed a number instead of a 'yes' or 'no'. Could you please provide the number for me? We're almost through this.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow and provided a boolean answer ('Yes') when a numerical input was expected. The best action is to continue the prescreening by gently correcting the user and re-prompting for the correct data type. The response clarifies the need for a number in a supportive and encouraging way, ensuring the user doesn't feel they made an error. The state remains 'prescreening_active' because we are still on the same eligibility question."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.14183497428894,
            "timestamp": "2025-12-19T10:10:30.251034"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. My apologies, I should have been more specific. The last question requires a number to help check your eligibility accurately. Could you please provide the answer as a number?",
                "new_state": "prescreening_active",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and responded with 'Yes'. The system's analysis indicates that a numerical answer was expected for the previous question. Instead of proceeding with incomplete information or causing an error, the best action is to continue the prescreening by politely clarifying the required input format and re-asking for a number. This keeps the conversation on track and ensures accurate data collection for the eligibility check, while maintaining a helpful and supportive tone."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.740525007247925,
            "timestamp": "2025-12-19T10:10:52.992142"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "I appreciate the response! For this particular question, I'll need a number to move forward. Could you please tell me how many inflammatory acne lesions (pimples and pustules) you have on your face? An estimate is perfectly fine.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a boolean 'Yes' when a numeric value was expected. The chosen action is to continue the prescreening by gently re-prompting for the required number. The response clarifies the need for a numeric input while maintaining a supportive and conversational tone, ensuring the user can proceed with the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 35.62740206718445,
            "timestamp": "2025-12-19T10:11:28.620056"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. My apologies if my last question wasn't clear. I actually need a specific number to continue with the eligibility check. Could you please tell me, approximately how many active acne spots (pimples, pustules, or cysts) you currently have on your face?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a 'Yes' response where a numerical answer was expected, as indicated by the OpenAI reasoning. The chosen action is `continue_prescreening` with a clarifying response. The response re-asks the likely previous question in a clear, empathetic way, guiding the user to provide the necessary numerical information to proceed with the eligibility check. The state remains `prescreening_active` as we are re-prompting for the current step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.217983961105347,
            "timestamp": "2025-12-19T10:11:52.838605"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find a number in your response. Could you please provide a numeric value?\n\nExamples: '3', 'zero', '0', '15'",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. For this particular question, I'll need a specific number to check the eligibility criteria. Could you please provide that for me? Just your best estimate is all that's needed.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has responded with 'Yes', but the context indicates a numerical answer was expected. The best action is to continue the prescreening by gently re-prompting for the required information. The response clarifies the need for a number in a supportive way, ensuring the conversation stays on track to complete the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 38.22946500778198,
            "timestamp": "2025-12-19T10:12:31.068440"
          }
        ],
        "final_state": "completed",
        "total_turns": 32,
        "total_questions_asked": 4,
        "errors": [
          {
            "type": "too_many_turns",
            "turns_processed": 30
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 50.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": false,
          "score": 0.0,
          "total_questions_asked": 4,
          "issues": [
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y...",
            "Repeated question: I couldn't find a number in your response. Could y..."
          ],
          "failures": [
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find a number in your response. Could y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            }
          ]
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": false,
          "failures": []
        },
        "performance": {
          "passed": false,
          "score": 40.0,
          "avg_response_time": 24.53239093720913,
          "max_response_time": 56.8698570728302,
          "status": "slow",
          "failures": [
            {
              "type": "performance_issue",
              "avg_response_time": 24.53239093720913,
              "max_response_time": 56.8698570728302,
              "severity": "low",
              "recommendation": "Investigate slow API responses or Gemini API delays"
            }
          ]
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find a number in your response. Could y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "performance_issue",
            "avg_response_time": 24.53239093720913,
            "max_response_time": 56.8698570728302,
            "severity": "low",
            "recommendation": "Investigate slow API responses or Gemini API delays"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py",
          "\u26a0\ufe0f MEDIUM: Major conversation quality issues. Review question generation and response handling.",
          "\u2139\ufe0f LOW: Slow response times. Optimize API calls or consider caching."
        ]
      },
      "timestamp": "2025-12-19T10:12:31.068963"
    },
    {
      "patient_id": "AUTO_TEST_random_001",
      "patient_profile": {
        "patient_id": "AUTO_TEST_random_001",
        "profile_type": "random",
        "demographics": {
          "age": 62,
          "gender": "non-binary",
          "location": "Charlotte, NC",
          "name": "Mary Martinez",
          "first_name": "Mary",
          "last_name": "Martinez"
        },
        "medical_history": {
          "primary_condition": "Bipolar Depression",
          "conditions": [
            "Bipolar Depression",
            "Substance Use"
          ],
          "medications": [
            "Quetiapine",
            "Lithium",
            "Valproate"
          ],
          "duration_years": 8
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            4,
            8
          ]
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_random_001",
        "patient_id": "AUTO_TEST_random_001",
        "conversation_log": [
          {
            "user_message": "Bipolar Depression trials in Charlotte, NC",
            "bot_response": "Great! I found 1 clinical trial(s) available in Charlotte, NC:\n\n**Dr. Keith Logan**\n  \u2022 Bipolar Depression (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": "Charlotte",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Bipolar Depression",
                  "location": "Charlotte, NC"
                },
                "response_text": "Of course. It takes courage to explore new treatment options for Bipolar Depression, and I'm here to help you look into what's available. I'm searching for clinical trials in the Charlotte, NC area now.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both a specific condition ('Bipolar Depression') and a location ('Charlotte, NC'). According to the action guidelines, the `search_trials` action is the correct next step as all necessary information for a search has been provided. The response confirms the user's request, offers empathy, and sets the expectation that a search is being performed, transitioning the state to `trials_found`."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true
            },
            "response_time": 16.774227142333984,
            "timestamp": "2025-12-19T10:12:47.843764"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the bipolar depression trial.\n\n**Question 1 of 4:** How old were you when this condition first started?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Great! I can help with that. I'll ask a few questions to see if you might be a match for any of these studies. Please remember, this is just a preliminary check and not medical advice.\n\nFirst, how old are you?",
                "new_state": "prescreening",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly confirmed they want to check their eligibility for the trials that were just presented (current state is 'trials_shown'). The most appropriate action is to begin the prescreening process. The first standard question in a prescreening flow is typically age, as it's a common and critical eligibility criterion. The state is transitioned to 'prescreening' to reflect this new phase of the conversation."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 0,
              "total_questions": 4,
              "current_question": "How old were you when this condition first started?",
              "expected_answer_type": "number"
            },
            "response_time": 18.740421056747437,
            "timestamp": "2025-12-19T10:13:06.584606"
          },
          {
            "user_message": "62",
            "bot_response": "Got it.\n\nHow many episodes have you had in the past 12 months?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 62,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for sharing that. Just a couple more questions to go. Are you currently taking any medications for Bipolar Depression?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just answered a question about their age. The correct action is to continue the prescreening process by asking the next logical eligibility question. The chosen question about current medication is a common and crucial criterion for Bipolar Depression trials. The response acknowledges their answer and clearly states the next question to keep the process moving forward smoothly."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 4,
              "current_question": "How many episodes have you had in the past 12 months?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 24.575754165649414,
            "timestamp": "2025-12-19T10:13:31.160947"
          },
          {
            "user_message": "3",
            "bot_response": "I couldn't determine if your answer is yes or no. Could you please respond with 'yes' or 'no'?\n\nPlease answer: 'yes' or 'no'",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 3,
                "medication": null,
                "number": 3,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for sharing that. Just a couple more questions to go. Are you currently taking any medication for your bipolar depression?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a direct numerical answer to the previous question. The correct action is to continue the prescreening flow by asking the next logical eligibility question. A question about current medication is a common and important criterion for bipolar depression trials. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 17.38285183906555,
            "timestamp": "2025-12-19T10:13:48.544254"
          },
          {
            "user_message": "Yes",
            "bot_response": "Thank you.\n\nWhat is your current weight and height?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it. Thanks for sharing. Just a couple more questions to go. Are you currently taking any medication for Bipolar Depression?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided a direct 'Yes' answer to the previous question. The correct action is to continue the prescreening process by asking the next relevant eligibility question. This moves the user closer to their goal of checking potential eligibility for a trial. The chosen question about current medication is a common and logical next step for a Bipolar Depression trial prescreener."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 2,
              "total_questions": 4,
              "current_question": "What is your current weight and height?",
              "expected_answer_type": "text",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 26.332481145858765,
            "timestamp": "2025-12-19T10:14:14.877363"
          },
          {
            "user_message": "5'9\", 158 lbs",
            "bot_response": "Thank you for that information.\n\nDo you have any medical conditions that might prevent you from participating in this study?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": [
                  5,
                  9,
                  158
                ],
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for sharing that. Just a couple more questions. Have you been diagnosed with any other major psychiatric conditions, such as schizophrenia or an anxiety disorder?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "condition"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just answered a question about their height and weight. The most logical next step is to continue with the next question in the prescreening flow to gather all necessary eligibility information. The chosen response acknowledges their answer and smoothly transitions to the next relevant question in a conversational manner."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              }
            },
            "response_time": 21.777010917663574,
            "timestamp": "2025-12-19T10:14:36.654935"
          },
          {
            "user_message": "Yes, I have Bipolar Depression",
            "bot_response": "Thanks for completing the prescreening! I have a few questions that need clarification:\n\n\u2713 Response: 62\n? Episodes/Count: Yes - needs clarification\n\u2713 BMI: 23.3 (Height: 5'9\", Weight: 158 lbs)\n\u2713 Current condition: Yes\n\nWould you like to:\n1. Continue with your current answers\n2. Update any responses\n\nPlease respond with '1' to continue or '2' to make changes.",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for confirming that. The next question is about age, as trials often have specific age requirements. May I ask how old you are?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their condition. The most appropriate action is to continue with the next question in the prescreening flow to determine their eligibility. Asking for their age is a standard and logical next step in this process. The state remains 'prescreening_active' as the session is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "pending_evaluation": true,
              "eligibility_result": {
                "trial_id": 112,
                "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                "overall_status": "likely_ineligible",
                "inclusion_met": 2,
                "inclusion_total": 3,
                "exclusion_met": 0,
                "exclusion_total": 1,
                "detailed_results": [
                  {
                    "criterion_id": 2789,
                    "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                    "user_answer": "62",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "Value 62.0 is within required range 18.0-74.0"
                  },
                  {
                    "criterion_id": 2792,
                    "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                    "user_answer": "Yes",
                    "eligible": null,
                    "status": "needs_review",
                    "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                  },
                  {
                    "criterion_id": 2790,
                    "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                    "user_answer": "5'9\", 158 lbs",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "BMI 23.3 (calculated from 175cm, 71.7kg): Value 23.332262753582427 is within required range 18.0-40.0"
                  },
                  {
                    "criterion_id": 2800,
                    "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                    "user_answer": "Yes, I have Bipolar Depression",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  }
                ],
                "summary_text": "Eligibility Summary for the bipolar depression trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/1\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2713 Age 62 (meets requirement)\n\u2713 BMI 23.3 (meets requirement)\n"
              },
              "summary": "\u2713 Response: 62\n? Episodes/Count: Yes - needs clarification\n\u2713 BMI: 23.3 (Height: 5'9\", Weight: 158 lbs)\n\u2713 Current condition: Yes"
            },
            "response_time": 22.298717975616455,
            "timestamp": "2025-12-19T10:14:58.954840"
          },
          {
            "user_message": "Yes, everything is correct. Please continue with the eligibility evaluation.",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for confirming that. The next question is about age, as trials often have specific age requirements. May I ask how old you are?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their condition. The most appropriate action is to continue with the next question in the prescreening flow to determine their eligibility. Asking for their age is a standard and logical next step in this process. The state remains 'prescreening_active' as the session is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "pending_evaluation": true,
              "eligibility_result": {
                "trial_id": 112,
                "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                "overall_status": "likely_ineligible",
                "inclusion_met": 2,
                "inclusion_total": 3,
                "exclusion_met": 0,
                "exclusion_total": 1,
                "detailed_results": [
                  {
                    "criterion_id": 2789,
                    "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                    "user_answer": "62",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "Value 62.0 is within required range 18.0-74.0"
                  },
                  {
                    "criterion_id": 2792,
                    "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                    "user_answer": "Yes",
                    "eligible": null,
                    "status": "needs_review",
                    "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                  },
                  {
                    "criterion_id": 2790,
                    "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                    "user_answer": "5'9\", 158 lbs",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "BMI 23.3 (calculated from 175cm, 71.7kg): Value 23.332262753582427 is within required range 18.0-40.0"
                  },
                  {
                    "criterion_id": 2800,
                    "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                    "user_answer": "Yes, I have Bipolar Depression",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  }
                ],
                "summary_text": "Eligibility Summary for the bipolar depression trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/1\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2713 Age 62 (meets requirement)\n\u2713 BMI 23.3 (meets requirement)\n"
              },
              "summary": "\u2713 Response: 62\n? Episodes/Count: Yes - needs clarification\n\u2713 BMI: 23.3 (Height: 5'9\", Weight: 158 lbs)\n\u2713 Current condition: Yes"
            },
            "response_time": 7.478312969207764,
            "timestamp": "2025-12-19T10:15:06.434423"
          },
          {
            "user_message": "Yes, please continue",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for confirming that. The next question is about age, as trials often have specific age requirements. May I ask how old you are?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their condition. The most appropriate action is to continue with the next question in the prescreening flow to determine their eligibility. Asking for their age is a standard and logical next step in this process. The state remains 'prescreening_active' as the session is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "pending_evaluation": true,
              "eligibility_result": {
                "trial_id": 112,
                "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                "overall_status": "likely_ineligible",
                "inclusion_met": 2,
                "inclusion_total": 3,
                "exclusion_met": 0,
                "exclusion_total": 1,
                "detailed_results": [
                  {
                    "criterion_id": 2789,
                    "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                    "user_answer": "62",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "Value 62.0 is within required range 18.0-74.0"
                  },
                  {
                    "criterion_id": 2792,
                    "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                    "user_answer": "Yes",
                    "eligible": null,
                    "status": "needs_review",
                    "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                  },
                  {
                    "criterion_id": 2790,
                    "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                    "user_answer": "5'9\", 158 lbs",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "BMI 23.3 (calculated from 175cm, 71.7kg): Value 23.332262753582427 is within required range 18.0-40.0"
                  },
                  {
                    "criterion_id": 2800,
                    "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                    "user_answer": "Yes, I have Bipolar Depression",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  }
                ],
                "summary_text": "Eligibility Summary for the bipolar depression trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/1\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2713 Age 62 (meets requirement)\n\u2713 BMI 23.3 (meets requirement)\n"
              },
              "summary": "\u2713 Response: 62\n? Episodes/Count: Yes - needs clarification\n\u2713 BMI: 23.3 (Height: 5'9\", Weight: 158 lbs)\n\u2713 Current condition: Yes"
            },
            "response_time": 9.367970705032349,
            "timestamp": "2025-12-19T10:15:15.806793"
          },
          {
            "user_message": "Yes, please continue",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for confirming that. The next question is about age, as trials often have specific age requirements. May I ask how old you are?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their condition. The most appropriate action is to continue with the next question in the prescreening flow to determine their eligibility. Asking for their age is a standard and logical next step in this process. The state remains 'prescreening_active' as the session is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "pending_evaluation": true,
              "eligibility_result": {
                "trial_id": 112,
                "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                "overall_status": "likely_ineligible",
                "inclusion_met": 2,
                "inclusion_total": 3,
                "exclusion_met": 0,
                "exclusion_total": 1,
                "detailed_results": [
                  {
                    "criterion_id": 2789,
                    "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                    "user_answer": "62",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "Value 62.0 is within required range 18.0-74.0"
                  },
                  {
                    "criterion_id": 2792,
                    "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                    "user_answer": "Yes",
                    "eligible": null,
                    "status": "needs_review",
                    "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                  },
                  {
                    "criterion_id": 2790,
                    "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                    "user_answer": "5'9\", 158 lbs",
                    "eligible": true,
                    "status": "confirmed",
                    "explanation": "BMI 23.3 (calculated from 175cm, 71.7kg): Value 23.332262753582427 is within required range 18.0-40.0"
                  },
                  {
                    "criterion_id": 2800,
                    "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                    "user_answer": "Yes, I have Bipolar Depression",
                    "eligible": false,
                    "status": "likely_ineligible",
                    "explanation": "Meets exclusion criterion"
                  }
                ],
                "summary_text": "Eligibility Summary for the bipolar depression trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/1\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2713 Age 62 (meets requirement)\n\u2713 BMI 23.3 (meets requirement)\n"
              },
              "summary": "\u2713 Response: 62\n? Episodes/Count: Yes - needs clarification\n\u2713 BMI: 23.3 (Height: 5'9\", Weight: 158 lbs)\n\u2713 Current condition: Yes"
            },
            "response_time": 10.922726154327393,
            "timestamp": "2025-12-19T10:15:26.732149"
          }
        ],
        "final_state": "completed",
        "total_turns": 10,
        "total_questions_asked": 4,
        "errors": [
          {
            "type": "unexpected_state",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your respo"
          },
          {
            "type": "unexpected_state",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your respo"
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 70.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": true,
          "score": 100.0,
          "total_questions_asked": 4,
          "issues": [],
          "failures": []
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": false,
          "failures": []
        },
        "performance": {
          "passed": true,
          "score": 70.0,
          "avg_response_time": 17.565047407150267,
          "max_response_time": 26.332481145858765,
          "status": "acceptable",
          "failures": []
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py"
        ]
      },
      "timestamp": "2025-12-19T10:15:26.733145"
    },
    {
      "patient_id": "AUTO_TEST_edge_multimorbid_000",
      "patient_profile": {
        "patient_id": "AUTO_TEST_edge_multimorbid_000",
        "profile_type": "edge_case",
        "demographics": {
          "age": 70,
          "gender": "female",
          "location": "Charlotte, NC",
          "name": "Multi Condition Patient",
          "first_name": "Multi",
          "last_name": "Patient"
        },
        "medical_history": {
          "primary_condition": "Bipolar Depression",
          "conditions": [
            "Bipolar Depression",
            "Major Depressive Disorder",
            "Type 2 Diabetes",
            "Androgenetic Alopecia"
          ],
          "medications": [
            "Biotin",
            "Jardiance",
            "Finasteride",
            "Metformin",
            "Sertraline",
            "Escitalopram",
            "Ozempic"
          ],
          "duration_years": 10
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": false,
          "expected_question_count_range": [
            5,
            10
          ],
          "edge_case_type": "multi_morbidity"
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_edge_multimorbid_000",
        "patient_id": "AUTO_TEST_edge_multimorbid_000",
        "conversation_log": [
          {
            "user_message": "Bipolar Depression trials in Charlotte, NC",
            "bot_response": "Great! I found 1 clinical trial(s) available in Charlotte, NC:\n\n**Dr. Keith Logan**\n  \u2022 Bipolar Depression (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": "Charlotte",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Bipolar Depression",
                  "location": "Charlotte, NC"
                },
                "response_text": "Of course. I can look for clinical trials for Bipolar Depression in the Charlotte, NC area for you. Finding the right trial is an important step, and I'm here to help. I'm searching for options now. Once I have a list, we can also review the eligibility criteria for any that interest you. Please give me just a moment.",
                "new_state": "awaiting_search_results",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both a specific condition ('Bipolar Depression') and a location ('Charlotte, NC'), which are the two required pieces of information to perform a trial search. The `search_trials` action is the most direct and helpful next step. The response confirms the user's request, expresses empathy, and sets the expectation that eligibility screening is a potential next step, guiding the conversation forward."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true
            },
            "response_time": 19.566757917404175,
            "timestamp": "2025-12-19T10:12:50.637675"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the bipolar depression trial.\n\n**Question 1 of 4:** How old were you when this condition first started?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Great, I can help with that. I'll ask a few simple questions to see if you might be a match for any of these trials. To start, could you please tell me your age?",
                "new_state": "prescreening_started",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly consented to an eligibility check after being shown a list of trials (current state is 'trials_shown'). The 'start_prescreening' action is the correct next step. The response confirms their request, sets expectations for a short Q&A, and asks the first common eligibility question (age) to begin the process. The state is updated to 'prescreening_started' to reflect this new phase of the conversation."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 0,
              "total_questions": 4,
              "current_question": "How old were you when this condition first started?",
              "expected_answer_type": "number"
            },
            "response_time": 17.621039867401123,
            "timestamp": "2025-12-19T10:13:08.259108"
          },
          {
            "user_message": "70",
            "bot_response": "Got it.\n\nHow many episodes have you had in the past 12 months?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 70,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you. Next question: Are you currently taking any medication for your bipolar depression?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered the question about their age. The logical next step is to continue with the next question in the prescreening flow to gather more information about their eligibility. The next question asks about current medications, which is a common and important eligibility criterion. The state remains `prescreening_active`."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 4,
              "current_question": "How many episodes have you had in the past 12 months?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 19.671857833862305,
            "timestamp": "2025-12-19T10:13:27.931600"
          },
          {
            "user_message": "3",
            "bot_response": "I couldn't determine if your answer is yes or no. Could you please respond with 'yes' or 'no'?\n\nPlease answer: 'yes' or 'no'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 3,
                "medication": null,
                "number": 3,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for sharing that. Just a couple more questions. Are you currently taking any medication for bipolar depression?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a direct numerical answer to the previous question. The correct action is to continue the prescreening process by asking the next logical question. The state remains 'prescreening_active' as the process is not yet complete. The response acknowledges their input and asks a relevant follow-up question about medication, which is a standard part of eligibility screening for this condition."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 18.648335933685303,
            "timestamp": "2025-12-19T10:13:46.581962"
          },
          {
            "user_message": "Yes",
            "bot_response": "Thank you.\n\nWhat is your current weight and height?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you. Just a couple more questions to see if this trial might be a good fit. Are you currently taking any medication for Bipolar Depression?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a direct 'Yes' answer to the previous question. The correct action is to proceed to the next question in the prescreening sequence to continue determining their potential eligibility. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 2,
              "total_questions": 4,
              "current_question": "What is your current weight and height?",
              "expected_answer_type": "text",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 22.50409507751465,
            "timestamp": "2025-12-19T10:14:09.086765"
          },
          {
            "user_message": "5'3\", 217 lbs",
            "bot_response": "Thank you for that information.\n\nDo you have any medical conditions that might prevent you from participating in this study?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": [
                  "5'3\"",
                  "217"
                ],
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for that information. The next question is: how old are you?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just answered a question about their height and weight. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical question. Age is a fundamental eligibility criterion, making it a natural next step in the sequence. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              }
            },
            "response_time": 21.14864420890808,
            "timestamp": "2025-12-19T10:14:30.236042"
          },
          {
            "user_message": "Yes, I have Bipolar Depression",
            "bot_response": "Thanks for completing the prescreening!\n\nEligibility Summary for the bipolar depression trial\n\n\u2717 You may not be eligible for this trial.\n\n\u2022 Inclusion criteria met: 2/3\n\u2022 Exclusion criteria passed: 0/1\n\n? Requirement needs review\n\u2717 Meets exclusion criterion\n\u2713 Age 70 (meets requirement)\n\u2713 BMI 38.4 (meets requirement)\n\n\nWould you like our research team to contact you regarding the bipolar depression trial? \n\nOur team will call within 1-2 business days to review your results and discuss next steps. Your information will be kept secure.\n\nPlease respond with 'yes' to provide your contact information, or 'no' if you prefer not to be contacted.",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_complete",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for sharing that with me. To continue, could you tell me if you are currently taking any medications for Bipolar Depression or any other condition?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their medical condition. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The state remains 'prescreening_active' as the screening is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_complete": true,
              "contact_collection_initiated": true,
              "trial_id": 112,
              "overall_status": "likely_ineligible",
              "inclusion_met": 2,
              "inclusion_total": 3,
              "exclusion_met": 0,
              "exclusion_total": 1,
              "detailed_results": [
                {
                  "criterion_id": 2789,
                  "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                  "user_answer": "70",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "Value 70.0 is within required range 18.0-74.0"
                },
                {
                  "criterion_id": 2792,
                  "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                  "user_answer": "Yes",
                  "eligible": null,
                  "status": "needs_review",
                  "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                },
                {
                  "criterion_id": 2790,
                  "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                  "user_answer": "5'3\", 217 lbs",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "BMI 38.4 (calculated from 160cm, 98.4kg): Value 38.439398924653226 is within required range 18.0-40.0"
                },
                {
                  "criterion_id": 2800,
                  "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                  "user_answer": "Yes, I have Bipolar Depression",
                  "eligible": false,
                  "status": "likely_ineligible",
                  "explanation": "Meets exclusion criterion"
                }
              ],
              "collected_answers": [
                {
                  "question": "How old were you when this condition first started?",
                  "response": "70",
                  "interpretation": "number",
                  "confidence": 1.0
                },
                {
                  "question": "How many episodes have you had in the past 12 months?",
                  "response": "Yes",
                  "interpretation": "yes",
                  "confidence": 1.0
                },
                {
                  "question": "What is your current weight and height?",
                  "response": "5'3\", 217 lbs",
                  "interpretation": "text",
                  "confidence": 1.0
                },
                {
                  "question": "Do you have any medical conditions that might prevent you from participating in this study?",
                  "response": "Yes, I have Bipolar Depression",
                  "interpretation": "yes",
                  "confidence": 1.0
                }
              ]
            },
            "response_time": 20.138310194015503,
            "timestamp": "2025-12-19T10:14:50.375026"
          },
          {
            "user_message": "Yes, please connect me",
            "bot_response": "Thank you! I'll collect a few pieces of information. First, what is your first name?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_complete",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for sharing that with me. To continue, could you tell me if you are currently taking any medications for Bipolar Depression or any other condition?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their medical condition. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The state remains 'prescreening_active' as the screening is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "prescreening_complete": true,
              "contact_collection_initiated": true,
              "overall_status": "likely_ineligible",
              "inclusion_met": 2,
              "inclusion_total": 3,
              "exclusion_met": 0,
              "exclusion_total": 1,
              "detailed_results": [
                {
                  "criterion_id": 2789,
                  "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                  "user_answer": "70",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "Value 70.0 is within required range 18.0-74.0"
                },
                {
                  "criterion_id": 2792,
                  "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                  "user_answer": "Yes",
                  "eligible": null,
                  "status": "needs_review",
                  "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                },
                {
                  "criterion_id": 2790,
                  "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                  "user_answer": "5'3\", 217 lbs",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "BMI 38.4 (calculated from 160cm, 98.4kg): Value 38.439398924653226 is within required range 18.0-40.0"
                },
                {
                  "criterion_id": 2800,
                  "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                  "user_answer": "Yes, I have Bipolar Depression",
                  "eligible": false,
                  "status": "likely_ineligible",
                  "explanation": "Meets exclusion criterion"
                }
              ],
              "collected_answers": [
                {
                  "question": "How old were you when this condition first started?",
                  "response": "70",
                  "interpretation": "number",
                  "confidence": 1.0
                },
                {
                  "question": "How many episodes have you had in the past 12 months?",
                  "response": "Yes",
                  "interpretation": "yes",
                  "confidence": 1.0
                },
                {
                  "question": "What is your current weight and height?",
                  "response": "5'3\", 217 lbs",
                  "interpretation": "text",
                  "confidence": 1.0
                },
                {
                  "question": "Do you have any medical conditions that might prevent you from participating in this study?",
                  "response": "Yes, I have Bipolar Depression",
                  "interpretation": "yes",
                  "confidence": 1.0
                }
              ]
            },
            "response_time": 9.214366912841797,
            "timestamp": "2025-12-19T10:14:59.591438"
          },
          {
            "user_message": "Multi",
            "bot_response": "Thank you, Multi! Now, what is your last name?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_complete",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for sharing that with me. To continue, could you tell me if you are currently taking any medications for Bipolar Depression or any other condition?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their medical condition. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The state remains 'prescreening_active' as the screening is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "prescreening_complete": true,
              "contact_collection_initiated": true,
              "overall_status": "likely_ineligible",
              "inclusion_met": 2,
              "inclusion_total": 3,
              "exclusion_met": 0,
              "exclusion_total": 1,
              "detailed_results": [
                {
                  "criterion_id": 2789,
                  "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                  "user_answer": "70",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "Value 70.0 is within required range 18.0-74.0"
                },
                {
                  "criterion_id": 2792,
                  "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                  "user_answer": "Yes",
                  "eligible": null,
                  "status": "needs_review",
                  "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                },
                {
                  "criterion_id": 2790,
                  "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                  "user_answer": "5'3\", 217 lbs",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "BMI 38.4 (calculated from 160cm, 98.4kg): Value 38.439398924653226 is within required range 18.0-40.0"
                },
                {
                  "criterion_id": 2800,
                  "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                  "user_answer": "Yes, I have Bipolar Depression",
                  "eligible": false,
                  "status": "likely_ineligible",
                  "explanation": "Meets exclusion criterion"
                }
              ],
              "collected_answers": [
                {
                  "question": "How old were you when this condition first started?",
                  "response": "70",
                  "interpretation": "number",
                  "confidence": 1.0
                },
                {
                  "question": "How many episodes have you had in the past 12 months?",
                  "response": "Yes",
                  "interpretation": "yes",
                  "confidence": 1.0
                },
                {
                  "question": "What is your current weight and height?",
                  "response": "5'3\", 217 lbs",
                  "interpretation": "text",
                  "confidence": 1.0
                },
                {
                  "question": "Do you have any medical conditions that might prevent you from participating in this study?",
                  "response": "Yes, I have Bipolar Depression",
                  "interpretation": "yes",
                  "confidence": 1.0
                }
              ]
            },
            "response_time": 11.690146923065186,
            "timestamp": "2025-12-19T10:15:11.284077"
          },
          {
            "user_message": "Patient",
            "bot_response": "Thank you! Next, please provide your phone number where our team can reach you.",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_complete",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for sharing that with me. To continue, could you tell me if you are currently taking any medications for Bipolar Depression or any other condition?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their medical condition. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The state remains 'prescreening_active' as the screening is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "prescreening_complete": true,
              "contact_collection_initiated": true,
              "overall_status": "likely_ineligible",
              "inclusion_met": 2,
              "inclusion_total": 3,
              "exclusion_met": 0,
              "exclusion_total": 1,
              "detailed_results": [
                {
                  "criterion_id": 2789,
                  "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                  "user_answer": "70",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "Value 70.0 is within required range 18.0-74.0"
                },
                {
                  "criterion_id": 2792,
                  "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                  "user_answer": "Yes",
                  "eligible": null,
                  "status": "needs_review",
                  "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                },
                {
                  "criterion_id": 2790,
                  "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                  "user_answer": "5'3\", 217 lbs",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "BMI 38.4 (calculated from 160cm, 98.4kg): Value 38.439398924653226 is within required range 18.0-40.0"
                },
                {
                  "criterion_id": 2800,
                  "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                  "user_answer": "Yes, I have Bipolar Depression",
                  "eligible": false,
                  "status": "likely_ineligible",
                  "explanation": "Meets exclusion criterion"
                }
              ],
              "collected_answers": [
                {
                  "question": "How old were you when this condition first started?",
                  "response": "70",
                  "interpretation": "number",
                  "confidence": 1.0
                },
                {
                  "question": "How many episodes have you had in the past 12 months?",
                  "response": "Yes",
                  "interpretation": "yes",
                  "confidence": 1.0
                },
                {
                  "question": "What is your current weight and height?",
                  "response": "5'3\", 217 lbs",
                  "interpretation": "text",
                  "confidence": 1.0
                },
                {
                  "question": "Do you have any medical conditions that might prevent you from participating in this study?",
                  "response": "Yes, I have Bipolar Depression",
                  "interpretation": "yes",
                  "confidence": 1.0
                }
              ]
            },
            "response_time": 13.04285717010498,
            "timestamp": "2025-12-19T10:15:24.328315"
          },
          {
            "user_message": "555-bid_000",
            "bot_response": "Please provide a valid phone number (for example: 555-123-4567 or (555) 123-4567).",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_complete",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for sharing that with me. To continue, could you tell me if you are currently taking any medications for Bipolar Depression or any other condition?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their medical condition. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The state remains 'prescreening_active' as the screening is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "prescreening_complete": true,
              "contact_collection_initiated": true,
              "overall_status": "likely_ineligible",
              "inclusion_met": 2,
              "inclusion_total": 3,
              "exclusion_met": 0,
              "exclusion_total": 1,
              "detailed_results": [
                {
                  "criterion_id": 2789,
                  "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                  "user_answer": "70",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "Value 70.0 is within required range 18.0-74.0"
                },
                {
                  "criterion_id": 2792,
                  "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                  "user_answer": "Yes",
                  "eligible": null,
                  "status": "needs_review",
                  "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                },
                {
                  "criterion_id": 2790,
                  "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                  "user_answer": "5'3\", 217 lbs",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "BMI 38.4 (calculated from 160cm, 98.4kg): Value 38.439398924653226 is within required range 18.0-40.0"
                },
                {
                  "criterion_id": 2800,
                  "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                  "user_answer": "Yes, I have Bipolar Depression",
                  "eligible": false,
                  "status": "likely_ineligible",
                  "explanation": "Meets exclusion criterion"
                }
              ],
              "collected_answers": [
                {
                  "question": "How old were you when this condition first started?",
                  "response": "70",
                  "interpretation": "number",
                  "confidence": 1.0
                },
                {
                  "question": "How many episodes have you had in the past 12 months?",
                  "response": "Yes",
                  "interpretation": "yes",
                  "confidence": 1.0
                },
                {
                  "question": "What is your current weight and height?",
                  "response": "5'3\", 217 lbs",
                  "interpretation": "text",
                  "confidence": 1.0
                },
                {
                  "question": "Do you have any medical conditions that might prevent you from participating in this study?",
                  "response": "Yes, I have Bipolar Depression",
                  "interpretation": "yes",
                  "confidence": 1.0
                }
              ]
            },
            "response_time": 11.22425889968872,
            "timestamp": "2025-12-19T10:15:35.554262"
          },
          {
            "user_message": "AUTO_TEST_edge_multimorbid_000@test.com",
            "bot_response": "Please provide a valid phone number (for example: 555-123-4567 or (555) 123-4567).",
            "metadata": {
              "session_id": "AUTO_TEST_edge_multimorbid_000",
              "current_state": "prescreening_complete",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Bipolar Depression",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for sharing that with me. To continue, could you tell me if you are currently taking any medications for Bipolar Depression or any other condition?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question about their medical condition. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The state remains 'prescreening_active' as the screening is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 1,
              "condition": "Bipolar Depression",
              "location": "Charlotte, NC",
              "trials_data": [
                {
                  "id": 112,
                  "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
                  "conditions": "Bipolar Depression",
                  "description": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "investigator_name": "Dr. Keith Logan",
                  "site_location": "Charlotte, NC",
                  "protocol_summary": "This is a Phase 3 clinical research study for a new investigational product for bipolar depression. It is a global study taking place at multiple centers. The study is \"randomized\" and \"double-blind,\" which means you will be assigned by chance (like a coin flip) to receive either the investigational product or a placebo, a pill with no active medicine. Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation in the study will last for approximately 18 weeks, which includes screening, a 6-week treatment period, and an 8-week follow-up period.\n\nThis study is looking for adults between the ages of 18 and 74 who have been diagnosed with Bipolar I or Bipolar II disorder and are currently experiencing a moderate to severe depressive episode. To be eligible, your current depressive episode must have lasted between 4 weeks and 12 months, and you must meet specific scores on depression rating scales. You may not be able to participate if you have recently had suicidal plans, have been found to be resistant to two or more previous treatments for your current episode, or are taking certain other psychiatric medications. The study team will review all eligibility criteria with you to determine if this study is a good fit.\n\nIf you join the study, you will take one capsule by mouth each day for 6 weeks; this will be either the investigational product or a placebo. The main purpose of the study is to see if the investigational product can reduce symptoms of depression more effectively than a placebo, which will be measured using a standard depression questionnaire (the MADRS). Researchers will also assess the product's effects on the loss of pleasure (anhedonia), its safety, and how quickly it may begin to work. Your participation will involve regular visits to the study center for assessments, which include questionnaires, vital signs checks, blood tests, and heart tracings (ECGs).",
                  "total_sites": 1,
                  "similarity_score": 0.8007777750156742
                }
              ],
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 112,
              "trial_name": "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Investigational Product in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Do you have any medical conditions that might prevent you from participating in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "prescreening_complete": true,
              "contact_collection_initiated": true,
              "overall_status": "likely_ineligible",
              "inclusion_met": 2,
              "inclusion_total": 3,
              "exclusion_met": 0,
              "exclusion_total": 1,
              "detailed_results": [
                {
                  "criterion_id": 2789,
                  "criterion_text": "Participant is \u226518 and \u226474 years of age at Visit 1. The first depressive episode must have occurred prior to 50 years of age.",
                  "user_answer": "70",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "Value 70.0 is within required range 18.0-74.0"
                },
                {
                  "criterion_id": 2792,
                  "criterion_text": "The current depressive episode must have a duration of \u22654 weeks and \u226412 months.",
                  "user_answer": "Yes",
                  "eligible": null,
                  "status": "needs_review",
                  "explanation": "Answer 'Yes' for criterion 'The current depressive episode must have a duration of \u22654 weeks and \u226412 months.' requires manual review by study staff"
                },
                {
                  "criterion_id": 2790,
                  "criterion_text": "Participant has a BMI \u226518 and \u226440 kg/m\u00b2.",
                  "user_answer": "5'3\", 217 lbs",
                  "eligible": true,
                  "status": "confirmed",
                  "explanation": "BMI 38.4 (calculated from 160cm, 98.4kg): Value 38.439398924653226 is within required range 18.0-40.0"
                },
                {
                  "criterion_id": 2800,
                  "criterion_text": "Participant has a substance use disorder (excluding tobacco) within the 6 months prior to Visit 1.",
                  "user_answer": "Yes, I have Bipolar Depression",
                  "eligible": false,
                  "status": "likely_ineligible",
                  "explanation": "Meets exclusion criterion"
                }
              ],
              "collected_answers": [
                {
                  "question": "How old were you when this condition first started?",
                  "response": "70",
                  "interpretation": "number",
                  "confidence": 1.0
                },
                {
                  "question": "How many episodes have you had in the past 12 months?",
                  "response": "Yes",
                  "interpretation": "yes",
                  "confidence": 1.0
                },
                {
                  "question": "What is your current weight and height?",
                  "response": "5'3\", 217 lbs",
                  "interpretation": "text",
                  "confidence": 1.0
                },
                {
                  "question": "Do you have any medical conditions that might prevent you from participating in this study?",
                  "response": "Yes, I have Bipolar Depression",
                  "interpretation": "yes",
                  "confidence": 1.0
                }
              ]
            },
            "response_time": 26.167256116867065,
            "timestamp": "2025-12-19T10:16:01.724163"
          }
        ],
        "final_state": "completed",
        "total_turns": 12,
        "total_questions_asked": 4,
        "errors": []
      },
      "validation": {
        "passed": false,
        "overall_score": 66.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": true,
          "score": 80.0,
          "total_questions_asked": 4,
          "issues": [
            "Too few questions asked (4, expected at least 5)"
          ],
          "failures": [
            {
              "type": "conversation_quality_issue",
              "issue": "Too few questions asked (4, expected at least 5)",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            }
          ]
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": true,
          "edge_case_type": "multi_morbidity",
          "completed": true,
          "failures": []
        },
        "performance": {
          "passed": true,
          "score": 70.0,
          "avg_response_time": 17.553160587946575,
          "max_response_time": 26.167256116867065,
          "status": "acceptable",
          "failures": []
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Too few questions asked (4, expected at least 5)",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py"
        ]
      },
      "timestamp": "2025-12-19T10:16:01.724504"
    },
    {
      "patient_id": "AUTO_TEST_targeted_diabetes_000",
      "patient_profile": {
        "patient_id": "AUTO_TEST_targeted_diabetes_000",
        "profile_type": "targeted",
        "demographics": {
          "age": 40,
          "gender": "female",
          "location": "Nashville, TN",
          "name": "Test Diabetes Patient",
          "first_name": "Test",
          "last_name": "Patient"
        },
        "medical_history": {
          "primary_condition": "Type 2 Diabetes",
          "conditions": [
            "Type 2 Diabetes",
            "Hypertension"
          ],
          "medications": [
            "Metformin",
            "Lisinopril"
          ],
          "duration_years": 7,
          "a1c": 8.2,
          "blood_glucose": 180
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            5,
            9
          ],
          "target_trial_keywords": [
            "diabetes"
          ]
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_targeted_diabetes_000",
        "patient_id": "AUTO_TEST_targeted_diabetes_000",
        "conversation_log": [
          {
            "user_message": "Type 2 Diabetes trials in Nashville, TN",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Type 2 Diabetes",
                "location": "Nashville",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN"
                },
                "response_text": "I can certainly help you look for Type 2 Diabetes trials in the Nashville, TN area. Let me run a search for you now. Once I find some options, we can also review the eligibility criteria for any that seem like a good fit.",
                "new_state": "awaiting_search_results",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both a specific condition ('Type 2 Diabetes') and a location ('Nashville, TN'), which are the two necessary pieces of information to perform a trial search. The intent is clearly `trial_search`. Therefore, the correct action is to execute the search and inform the user what I'm doing, while also setting the stage for the next logical step, which is discussing eligibility."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 15.164798259735107,
            "timestamp": "2025-12-19T10:16:16.889810"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville"
                },
                "response_text": "Great! To check your eligibility, I first need to find some relevant studies. Let me search for Type 2 Diabetes trials in the Nashville area for you now. I'll be right back with what I find, and then we can look at the eligibility criteria for any that catch your eye.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has confirmed they want to check eligibility. However, no trials have been presented yet. The logical first step is to perform the search using the condition and location we already have. The response acknowledges the user's ultimate goal (checking eligibility) while guiding them through the necessary prerequisite step (finding trials)."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville"
            },
            "response_time": 18.574318170547485,
            "timestamp": "2025-12-19T10:16:35.464569"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "Thanks for confirming you're in Nashville. It looks like there aren't any matching Type 2 Diabetes trials directly in the city at the moment. \n\nWould you be open to me expanding the search to a wider area, like within 50 miles? I can also check for any remote trials that you could participate in from home.",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {
                  "clarification_needed": "expand_search_radius"
                },
                "response_text": "Thanks for confirming you're in Nashville. It looks like there aren't any matching Type 2 Diabetes trials directly in the city at the moment. \n\nWould you be open to me expanding the search to a wider area, like within 50 miles? I can also check for any remote trials that you could participate in from home.",
                "new_state": "awaiting_clarification",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user has repeated their location, likely because the previous search yielded no results. Running the same search again would be unhelpful and create a frustrating loop. The best course of action is to acknowledge the lack of local results and proactively offer a constructive alternative. By suggesting an expanded search radius or remote trials, we provide a path forward and manage the user's expectations. This requires clarification from the user on how they wish to proceed, making 'clarify_request' the most appropriate action."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 22.76865267753601,
            "timestamp": "2025-12-19T10:16:58.234174"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN",
                  "search_radius": 50
                },
                "response_text": "Perfect. I'll go ahead and expand the search area. One moment while I look for Type 2 Diabetes clinical trials within 50 miles of Nashville for you.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has confirmed their agreement to expand the search area. Since we have both the necessary condition (Type 2 Diabetes) and location (Nashville, TN), the next logical step is to execute the search with the expanded radius. The response confirms this action to the user and sets the expectation that results will be provided shortly, moving the conversation into a state where trials can be presented."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 19.542530059814453,
            "timestamp": "2025-12-19T10:17:17.777272"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "Thanks for confirming your location in Nashville, TN. I apologize for any confusion, but it seems my previous search didn't find any matching Type 2 Diabetes trials right in that area. Sometimes trial availability can be limited.\n\nWould you be open to expanding the search to a wider radius, say 50 miles, to see if there's anything nearby?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "Thanks for confirming your location in Nashville, TN. I apologize for any confusion, but it seems my previous search didn't find any matching Type 2 Diabetes trials right in that area. Sometimes trial availability can be limited.\n\nWould you be open to expanding the search to a wider radius, say 50 miles, to see if there's anything nearby?",
                "new_state": "awaiting_radius_confirmation",
                "collect_entities": [
                  "boolean_answer",
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user has repeated their location, which we already have. The provided reasoning indicates a search was already performed and yielded no results. Simply re-running the same search would be unhelpful. The best course of action is to acknowledge their input, gently clarify that no trials were found in the immediate area, and proactively offer a constructive next step. Suggesting an expanded search radius is a common and helpful way to find more options for the user, moving the conversation forward from a dead end."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 33.34632611274719,
            "timestamp": "2025-12-19T10:17:51.124170"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN",
                  "search_radius": 100
                },
                "response_text": "Great, thanks for confirming. I'm now expanding the search for Type 2 Diabetes clinical trials to a wider area around Nashville. I'll share what I find in just a moment.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has confirmed their desire to expand the search radius. We have both the necessary condition ('Type 2 Diabetes') and location ('Nashville, TN'). Therefore, the most appropriate action is to perform the search with the expanded parameters. The response acknowledges their confirmation, states the action being taken, and sets the expectation that results are forthcoming. The state is updated to 'trials_found' to reflect that the next step will be presenting the search results."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 19.309492111206055,
            "timestamp": "2025-12-19T10:18:10.434027"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN"
                },
                "response_text": "Got it, thanks for confirming. I'll search again specifically for Type 2 Diabetes trials in Nashville, TN. Sometimes new studies are added, so it's always worth another look. One moment while I check for you.",
                "new_state": "search_initiated",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both their condition (Type 2 Diabetes) and their location (Nashville, TN). They have re-confirmed their location, indicating a clear intent to search in that specific area. The necessary information has been collected, so the next logical step is to perform the search for clinical trials as requested."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 17.437996864318848,
            "timestamp": "2025-12-19T10:18:27.872601"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN",
                  "radius": 50
                },
                "response_text": "Thanks for confirming. I'm searching for clinical trials for Type 2 Diabetes in and around Nashville, TN for you now. This may take just a moment.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both the required condition (from context) and location. The user's intent, especially given the context that they are repeating their location, is to initiate a search. The 'search_trials' action directly addresses this request and moves the conversation toward their goal of finding relevant trials. The response confirms the action and sets expectations."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 21.567972898483276,
            "timestamp": "2025-12-19T10:18:49.441293"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "Thanks for confirming your location in Nashville, TN. It seems there aren't any matching trials for Type 2 Diabetes right in your immediate area at the moment. Would you be open to broadening the search to the entire state of Tennessee, or perhaps looking for remote trials you could do from home?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "Thanks for confirming your location in Nashville, TN. It seems there aren't any matching trials for Type 2 Diabetes right in your immediate area at the moment. Would you be open to broadening the search to the entire state of Tennessee, or perhaps looking for remote trials you could do from home?",
                "new_state": "refining_search",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user has repeated their location after a previous search likely failed to find results. Simply re-running the search with the same parameters (Type 2 Diabetes in Nashville, TN) would be unhelpful and continue the conversational loop. The best action is to clarify the situation, explain why no results were found, and proactively offer alternative search strategies, such as broadening the location or searching for remote trials. This empowers the user and moves the conversation forward constructively."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 40.12680912017822,
            "timestamp": "2025-12-19T10:19:29.568924"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "Great. Just to be sure, which option sounds better to you? Should I broaden the search to include all of Tennessee, or would you prefer to look for remote trials that you can participate in from home?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "Great. Just to be sure, which option sounds better to you? Should I broaden the search to include all of Tennessee, or would you prefer to look for remote trials that you can participate in from home?",
                "new_state": "clarifying_search_scope",
                "collect_entities": [
                  "search_scope_preference"
                ],
                "metadata": {
                  "reasoning": "The user's affirmative response ('Yes') is ambiguous because the previous turn likely offered two distinct options (e.g., broaden the search to the state or look for remote trials). The chosen action is to clarify their preference to ensure the next step is accurate and helpful. The response re-presents the options clearly to guide the user toward a specific choice, preventing a frustrating or incorrect search."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 21.39763879776001,
            "timestamp": "2025-12-19T10:19:50.967051"
          },
          {
            "user_message": "I'm not sure, can you clarify?",
            "bot_response": "Of course, I'm happy to clarify. I can approach our search in two ways:\n\n1.  **Broad Search:** I can show you all the Type 2 Diabetes trials currently available near Nashville. This gives you the most comprehensive list to look through.\n\n2.  **Guided Search:** You can answer a few quick questions first (like how long you've had diabetes or current medications), and I'll use that information to find trials that are a more specific match for you.\n\nWhich approach sounds better to you?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "Of course, I'm happy to clarify. I can approach our search in two ways:\n\n1.  **Broad Search:** I can show you all the Type 2 Diabetes trials currently available near Nashville. This gives you the most comprehensive list to look through.\n\n2.  **Guided Search:** You can answer a few quick questions first (like how long you've had diabetes or current medications), and I'll use that information to find trials that are a more specific match for you.\n\nWhich approach sounds better to you?",
                "new_state": "awaiting_search_preference",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user is asking for clarification on the previous options presented. The best action is a `general_response` that re-explains the two search methods (a broad search vs. a guided/filtered search) in simple terms. This empowers the user to make an informed choice and moves the conversation forward toward finding relevant trials. The response is empathetic, clear, and directly addresses the user's request, setting a new state to track that we are now waiting for their decision on how to proceed with the search."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 22.5956552028656,
            "timestamp": "2025-12-19T10:20:13.563238"
          },
          {
            "user_message": "Yes, I'm taking Metformin, and Lisinopril",
            "bot_response": "I need to know which specific trial you'd like to check eligibility for. Could you please search for trials first, or let me know what condition and location you're interested in?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": [
                  "Metformin",
                  "Lisinopril"
                ],
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "medications": [
                    "Metformin",
                    "Lisinopril"
                  ]
                },
                "response_text": "Thank you for sharing that. It's really helpful for narrowing down the search. To continue, could you tell me approximately how long you've been diagnosed with Type 2 Diabetes?",
                "new_state": "awaiting_diagnosis_duration",
                "collect_entities": [
                  "duration"
                ],
                "metadata": {
                  "reasoning": "The user has provided their current medications in response to a prescreening question, indicating they are willing to continue the guided process. The current state is within a prescreening flow. The most logical next step is to ask another common eligibility question to further refine the trial search. Asking for the duration of their diagnosis is a standard and important question for Type 2 Diabetes trials. This action continues the data collection needed to find the most relevant trials for the user."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_error": "no_trial_id_found"
            },
            "response_time": 24.435254096984863,
            "timestamp": "2025-12-19T10:20:37.999116"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN"
                },
                "response_text": "Great, thank you. I'll start looking for Type 2 Diabetes clinical trials in the Nashville, TN area for you now. This may take a moment.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided their location, and we already have their condition from the conversation context. With both pieces of necessary information, the correct action is to initiate a search for clinical trials. The response confirms the search parameters and sets the user's expectation that the search is in progress. The state transitions to `trials_found` to prepare for displaying the results."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 17.30981183052063,
            "timestamp": "2025-12-19T10:20:55.309439"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "Thanks for confirming your location in Nashville, TN. I recall that my previous search for Type 2 Diabetes trials right in Nashville didn't turn up any results, and I want to make sure we find some options for you. Would you be open to broadening the search? We could look at trials across the entire state of Tennessee or check for any remote trials that you could participate in from home.",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "Thanks for confirming your location in Nashville, TN. I recall that my previous search for Type 2 Diabetes trials right in Nashville didn't turn up any results, and I want to make sure we find some options for you. Would you be open to broadening the search? We could look at trials across the entire state of Tennessee or check for any remote trials that you could participate in from home.",
                "new_state": "awaiting_clarification",
                "collect_entities": null,
                "metadata": {
                  "reasoning": "The user is repeating a location for which a previous search has already failed. Instead of re-running the same unsuccessful search, the best action is to clarify the situation and offer alternative, more productive search options like broadening the location or searching for remote trials. This prevents a frustrating loop and helps the user move forward."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 24.3587429523468,
            "timestamp": "2025-12-19T10:21:19.668942"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN",
                  "search_radius": 50
                },
                "response_text": "Great, I'll expand the search for you. One moment while I look for Type 2 Diabetes clinical trials within a 50-mile radius of Nashville, TN.",
                "new_state": "searching",
                "collect_entities": null,
                "metadata": {
                  "reasoning": "The user has provided a positive confirmation to the previous suggestion of broadening the search. Since we have both the condition and location, the next logical step is to perform the search with the expanded parameters as agreed upon. This action directly addresses the user's request and moves the conversation forward to the results phase."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 19.709582805633545,
            "timestamp": "2025-12-19T10:21:39.378964"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN"
                },
                "response_text": "Perfect, thank you for confirming. I am now searching for clinical trials for Type 2 Diabetes in and around Nashville, TN. Please give me just a moment to find the best matches for you.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has re-confirmed their location after a lengthy conversation (15 turns) where a search was discussed. We have all the necessary information (condition and location) to proceed. The most helpful and logical next step is to execute the search for clinical trials as the user expects. This action directly addresses their implicit request and moves the conversation toward their goal. The state is updated to `trials_found` to reflect the successful completion of the search action."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 21.556129932403564,
            "timestamp": "2025-12-19T10:22:00.935652"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN"
                },
                "response_text": "Got it, Nashville, TN. I have your condition as Type 2 Diabetes. Let me run a new search for you right now to see what trials are available in that area.",
                "new_state": "trials_presented",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both the necessary condition (Type 2 Diabetes from the context) and location (Nashville, TN). They are repeating the location, which strongly indicates a desire to initiate a search. The `search_trials` action is the most direct and helpful next step to move the conversation forward and meet the user's goal. The response confirms the search parameters and sets clear expectations."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 15.887334108352661,
            "timestamp": "2025-12-19T10:22:16.823413"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "Thanks for confirming. It looks like there aren't any active Type 2 Diabetes trials directly within Nashville at the moment. Sometimes the closest trials are in a nearby city. Would you be open to me expanding the search to a wider area, like the entire state of Tennessee?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "Thanks for confirming. It looks like there aren't any active Type 2 Diabetes trials directly within Nashville at the moment. Sometimes the closest trials are in a nearby city. Would you be open to me expanding the search to a wider area, like the entire state of Tennessee?",
                "new_state": "awaiting_search_clarification",
                "collect_entities": [
                  "boolean_answer",
                  "location"
                ],
                "metadata": {
                  "reasoning": "The user is repeating their location, likely because a previous search failed or yielded no results. Re-running the exact same search would be unhelpful and frustrating. The best action is to acknowledge their request, explain the lack of results for the specific location, and proactively offer a constructive solution by suggesting an expanded search area. This manages expectations, breaks the conversational loop, and provides a clear, helpful path forward."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 39.70062327384949,
            "timestamp": "2025-12-19T10:22:56.524793"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN",
                  "search_radius_miles": 100
                },
                "response_text": "Perfect. I'll expand the search for you now. Looking for clinical trials for Type 2 Diabetes in and around the Nashville area. This should just take a moment.",
                "new_state": "trials_presented",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has confirmed the suggestion to expand the search area. Since we have both the condition (Type 2 Diabetes) and location (Nashville, TN), the next logical step is to execute the search with the wider radius. The response acknowledges their confirmation, states the action being taken, and sets the expectation that results are forthcoming."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 22.699435234069824,
            "timestamp": "2025-12-19T10:23:19.224851"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN"
                },
                "response_text": "Perfect, thank you. I'm now searching for clinical trials for Type 2 Diabetes in the Nashville, TN area. Please give me just a moment to find the latest results for you.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided their location, and their condition (Type 2 Diabetes) is already known from the conversation context. With both necessary pieces of information, the correct action is to proceed with the search for clinical trials as per the user's implicit request. The response confirms the action and sets expectations for the user."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 20.258078813552856,
            "timestamp": "2025-12-19T10:23:39.483543"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN"
                },
                "response_text": "Great, thank you for confirming. I'll search for Type 2 Diabetes clinical trials in Nashville, TN right now. Please give me a moment to find the latest results for you.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided their location, and I already have their condition (Type 2 Diabetes) from the conversation context. With both necessary pieces of information, the next logical and helpful action is to perform the search for clinical trials. The response confirms the action and sets expectations for the user, acknowledging their input in a supportive manner."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 22.785165071487427,
            "timestamp": "2025-12-19T10:24:02.270058"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "Thanks for confirming your location is Nashville, TN. I did run a search for Type 2 Diabetes trials there, but unfortunately, I couldn't find any active studies right in that area. \n\nWould you like me to expand the search to a wider area around Nashville, or is there another city you'd be interested in checking?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {
                  "location": "Nashville, TN",
                  "condition": "Type 2 Diabetes"
                },
                "response_text": "Thanks for confirming your location is Nashville, TN. I did run a search for Type 2 Diabetes trials there, but unfortunately, I couldn't find any active studies right in that area. \n\nWould you like me to expand the search to a wider area around Nashville, or is there another city you'd be interested in checking?",
                "new_state": "awaiting_location_clarification",
                "collect_entities": [
                  "location",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is repeating their location after a previous search for 'Nashville, TN' yielded no results. Re-running the same search would be unhelpful and create a frustrating loop. The best action is to clarify that the search was already performed and offer alternative solutions, such as expanding the search radius or trying a different location. This proactively guides the user toward a more productive path."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 21.161670923233032,
            "timestamp": "2025-12-19T10:24:23.432451"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "My apologies for the confusion. To make sure I get this right, did you want me to expand the search radius around Nashville, or would you like to check for trials in a different city?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "My apologies for the confusion. To make sure I get this right, did you want me to expand the search radius around Nashville, or would you like to check for trials in a different city?",
                "new_state": "awaiting_clarification",
                "collect_entities": null,
                "metadata": {
                  "reasoning": "The user's response 'Yes, that's correct' is ambiguous because the previous question presented a choice between two distinct options (e.g., 'expand search' vs. 'new city'). The 'yes' doesn't specify which option they are confirming. The most helpful next step is to politely ask for clarification to ensure the next action aligns with the user's actual intent, preventing an incorrect search and keeping the conversation on track."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 24.477535247802734,
            "timestamp": "2025-12-19T10:24:47.910804"
          },
          {
            "user_message": "I'm not sure, can you clarify?",
            "bot_response": "Of course, I'm happy to clarify. We have two main paths we can take right now.\n\n1.  We can start searching for specific clinical trials for Type 2 Diabetes here in Nashville.\n2.  Or, we can take a step back and I can answer any general questions you might have about how clinical trials work.\n\nWhich of those sounds more helpful to you at the moment?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "Of course, I'm happy to clarify. We have two main paths we can take right now.\n\n1.  We can start searching for specific clinical trials for Type 2 Diabetes here in Nashville.\n2.  Or, we can take a step back and I can answer any general questions you might have about how clinical trials work.\n\nWhich of those sounds more helpful to you at the moment?",
                "new_state": "awaiting_user_direction",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has explicitly stated they are unsure and asked for clarification. The detected intent is 'general_query'. The most appropriate action is to clarify the options presented in the previous turn. This response re-explains the two primary paths the user can take (search for trials or get general information) in simple terms. It's empathetic, directly addresses their request, and aims to unblock the conversation by helping them make an informed choice. The state is updated to reflect that we are waiting for the user to decide on the direction of the conversation."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 52.61459994316101,
            "timestamp": "2025-12-19T10:25:40.525783"
          },
          {
            "user_message": "I'm not sure, can you clarify?",
            "bot_response": "I'm here to help you find clinical trials. What condition are you interested in?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "I'm here to help you find clinical trials. What condition are you interested in?",
                "new_state": "initial",
                "collect_entities": null,
                "metadata": {
                  "fallback": true
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 54.476332902908325,
            "timestamp": "2025-12-19T10:26:35.002861"
          },
          {
            "user_message": "Yes, I have Type 2 Diabetes",
            "bot_response": "I couldn't find any trials for Type 2 Diabetes in Nashville, TN at the moment. Would you like to try a different condition or location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Type 2 Diabetes",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Nashville, TN"
                },
                "response_text": "Great, thank you for confirming. Living with Type 2 Diabetes presents unique challenges, and exploring new treatment options is a proactive step. I'll now search for clinical trials for Type 2 Diabetes near Nashville, TN for you. This may take just a moment.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The system has successfully collected both the user's condition (Type 2 Diabetes) and location (Nashville, TN). With this necessary information, the next logical and helpful action is to perform the search for relevant clinical trials. The response confirms the search parameters, shows empathy for the user's condition, and sets expectations for the search process. The state is updated to reflect that a search has been initiated and results will be presented next."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "no_trials_found": true,
              "condition": "Type 2 Diabetes",
              "location": "Nashville, TN"
            },
            "response_time": 22.649317026138306,
            "timestamp": "2025-12-19T10:26:57.652802"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "I see you've confirmed Nashville, TN. I did search for Type 2 Diabetes trials in that area, but unfortunately, I couldn't find any active studies right now. Sometimes trials are located in larger medical centers nearby. Would you be open to expanding the search to a wider area, or perhaps looking for remote trials you could do from home?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "I see you've confirmed Nashville, TN. I did search for Type 2 Diabetes trials in that area, but unfortunately, I couldn't find any active studies right now. Sometimes trials are located in larger medical centers nearby. Would you be open to expanding the search to a wider area, or perhaps looking for remote trials you could do from home?",
                "new_state": "clarifying_search_scope",
                "collect_entities": null,
                "metadata": {
                  "reasoning": "The user has repeated their location after a search presumably yielded no results (inferred from the OpenAI reasoning and the high turn count). Running the same search again would be unhelpful and create a frustrating loop. The best action is to acknowledge their input, confirm the previous result, and proactively offer alternative, constructive next steps. This clarifies their intent and provides options like expanding the search radius or looking for remote trials, which directly addresses the problem of no local matches."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 24.84114408493042,
            "timestamp": "2025-12-19T10:27:22.494539"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "Thanks for confirming! Just to be sure I'm on the right track, did you want me to expand the search area around Nashville, or would you prefer to look for remote trials you can participate in from home?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "Thanks for confirming! Just to be sure I'm on the right track, did you want me to expand the search area around Nashville, or would you prefer to look for remote trials you can participate in from home?",
                "new_state": "awaiting_clarification",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user's response 'Yes, that's correct' is ambiguous, as the previous turn likely offered two distinct options (e.g., expanding the search radius or searching for remote trials). This action seeks to clarify which option the user prefers before proceeding, ensuring the next step is aligned with their actual intent. This prevents a frustrating conversational loop and moves the user closer to their goal of finding a suitable trial."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 20.712241888046265,
            "timestamp": "2025-12-19T10:27:43.207263"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "I'm happy to help with that! Just to be sure I'm on the right track, did you want me to expand the search area to find more trials near Nashville, or would you prefer to look for remote trials you can do from home?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "I'm happy to help with that! Just to be sure I'm on the right track, did you want me to expand the search area to find more trials near Nashville, or would you prefer to look for remote trials you can do from home?",
                "new_state": "awaiting_search_preference",
                "collect_entities": null,
                "metadata": {
                  "reasoning": "The user's response 'Yes, that's correct' is ambiguous given the previous turn offered a choice between two distinct options: expanding the search radius or looking for remote trials. The user's simple confirmation does not specify which option they prefer. Therefore, the most appropriate action is to clarify their intent by re-presenting the two choices clearly and politely. This ensures we proceed with the correct search and avoids making an incorrect assumption."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 24.347326040267944,
            "timestamp": "2025-12-19T10:28:07.555044"
          },
          {
            "user_message": "I'm not sure, can you clarify?",
            "bot_response": "Of course, I'm happy to clarify. We have everything we need to look for trials. My next step would be to search for Type 2 Diabetes clinical trials happening near you in Nashville. \n\nBefore I do that, I just wanted to check if you'd prefer that I first provide some general information about how clinical trials work. \n\nWhat sounds best to you right now: should I go ahead and search, or would you like a bit more information first?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "Of course, I'm happy to clarify. We have everything we need to look for trials. My next step would be to search for Type 2 Diabetes clinical trials happening near you in Nashville. \n\nBefore I do that, I just wanted to check if you'd prefer that I first provide some general information about how clinical trials work. \n\nWhat sounds best to you right now: should I go ahead and search, or would you like a bit more information first?",
                "new_state": "clarifying_next_step",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has expressed uncertainty and asked for clarification. Given that we have both their condition and location, the most likely point of confusion is about what happens next. The previous turn likely offered a choice between searching for trials or learning more about them. This response directly addresses the user's request by empathetically re-stating the two possible paths forward in a clear, simple manner. This empowers the user to make an informed choice and moves the conversation forward constructively without making assumptions about what they need clarified."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 24.920576095581055,
            "timestamp": "2025-12-19T10:28:32.476010"
          },
          {
            "user_message": "I'm not sure, can you clarify?",
            "bot_response": "Of course, I'm happy to clarify. My apologies if I wasn't clear before. Based on your condition and location, I can either show you a list of the clinical trials I found, or we can start by looking at the first trial and I can ask you a few questions to see if you might be a good match. This is a quick eligibility check to save you time. \n\nWould you prefer to see the list first, or start with the eligibility check for the top match?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "Of course, I'm happy to clarify. My apologies if I wasn't clear before. Based on your condition and location, I can either show you a list of the clinical trials I found, or we can start by looking at the first trial and I can ask you a few questions to see if you might be a good match. This is a quick eligibility check to save you time. \n\nWould you prefer to see the list first, or start with the eligibility check for the top match?",
                "new_state": "awaiting_user_choice",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has explicitly stated they are unsure and asked for clarification. The current context indicates we have the necessary information (condition, location) and have likely just offered the user a choice, such as viewing trials or starting a prescreening. The best action is to clarify these options. The response re-explains the two primary paths forward in simple terms (viewing a list vs. starting a guided eligibility check) and then re-presents the choice to the user. This directly addresses their request, is empathetic, and helps them make an informed decision to move the conversation forward."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 39.105141162872314,
            "timestamp": "2025-12-19T10:29:11.581845"
          },
          {
            "user_message": "Nashville, TN",
            "bot_response": "Thanks for confirming your location in Nashville, TN. I have the trial search ready for you. To make sure I get you what you need, would you like to see the list of trials first, or would you prefer to answer a few questions to check your eligibility for them?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_000",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": "Nashville, TN",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "Thanks for confirming your location in Nashville, TN. I have the trial search ready for you. To make sure I get you what you need, would you like to see the list of trials first, or would you prefer to answer a few questions to check your eligibility for them?",
                "new_state": "awaiting_clarification",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user repeated their location, which was already known, and did not answer the previous question about their desired next step (viewing trials vs. starting a prescreener). The best action is to clarify their intent to get the conversation back on track. This response acknowledges their input, gently re-orients them to the available options, and asks for a clear choice, ensuring we proceed in the most helpful way."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 22.553051948547363,
            "timestamp": "2025-12-19T10:29:34.135587"
          }
        ],
        "final_state": "completed",
        "total_turns": 32,
        "total_questions_asked": 0,
        "errors": [
          {
            "type": "too_many_turns",
            "turns_processed": 30
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 50.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": false,
          "score": 0.0,
          "total_questions_asked": 0,
          "issues": [
            "Too few questions asked (0, expected at least 5)",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "Repeated question: I couldn't find any trials for Type 2 Diabetes in ..."
          ],
          "failures": [
            {
              "type": "conversation_quality_issue",
              "issue": "Too few questions asked (0, expected at least 5)",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            }
          ]
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": false,
          "failures": []
        },
        "performance": {
          "passed": false,
          "score": 40.0,
          "avg_response_time": 25.387227676808834,
          "max_response_time": 54.476332902908325,
          "status": "slow",
          "failures": [
            {
              "type": "performance_issue",
              "avg_response_time": 25.387227676808834,
              "max_response_time": 54.476332902908325,
              "severity": "low",
              "recommendation": "Investigate slow API responses or Gemini API delays"
            }
          ]
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Too few questions asked (0, expected at least 5)",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find any trials for Type 2 Diabetes in ...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "performance_issue",
            "avg_response_time": 25.387227676808834,
            "max_response_time": 54.476332902908325,
            "severity": "low",
            "recommendation": "Investigate slow API responses or Gemini API delays"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py",
          "\u26a0\ufe0f MEDIUM: Major conversation quality issues. Review question generation and response handling.",
          "\u2139\ufe0f LOW: Slow response times. Optimize API calls or consider caching."
        ]
      },
      "timestamp": "2025-12-19T10:29:34.136370"
    }
  ]
}